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ABSTRACT 
 The vasculature is a highly complex, hierarchical system that performs a variety 
of functions in both physiological and pathological contexts.  To maintain tissue 
homeostasis for example, the endothelium which lines all vascular structures generates a 
semi-permeable barrier that controls the exchange of fluids, ions, and solutes between the 
blood and tissue.  During phases of tissue growth and wound repair, the vasculature 
undergoes angiogenesis, the development of new blood vessels, to provide adequate 
oxygen and nutrients to the new and healing tissues.  In pathological situations such as 
cancer, blood vessels have been demonstrated to support tumor growth and provide 
access to the circulatory system for metastatic progression.   
This dissertation focuses on elucidating new mechanisms that are involved in 
regulating these three dynamic functions of the vasculature.  In Chapter 2, we discuss 
preliminary work connecting the Notch signaling pathway with the ability for endothelial 
cells to mechanically couple to their substrate, a property that is known to regulate 
endothelial barrier function.  Using traditional methods in two-dimensional traction force 
 
 vii 
microscopy, we observed reductions in traction stresses generated by endothelial 
monolayers treated with a Notch inhibitor.  This was accompanied by a decrease in cell-
matrix tethering through focal adhesions.  In Chapter 3, we utilized an engineered model 
of angiogenesis to probe the role of endothelial cell contractility in the formation of new 
vascular sprouts.  Through these studies, we established an essential role of non-muscle 
myosin II in maintaining multicellularity during sprout morphogenesis.  And in Chapter 
4, we described the adaptation of a cranial window model for studying melanoma brain 
metastases and demonstrated the utility of this system to monitor dynamic interactions 
between cancer cells and the brain vasculature.  Together, the work in this dissertation 
provides new insights into and techniques for probing outstanding questions regarding 
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CHAPTER 1: AN INTRODUCTION TO VASCULAR FUNCTIONS 
1.1 Physiological Barrier Function of the Endothelium 
 The blood vasculature is an extensive hierarchical system consisting of large 
caliber vessels including arteries and veins as well as smaller caliber vessels like 
arterioles and venules (Tucker & Bhimiji 2017).  Arteries, the vascular structures that 
carry blood away from the heart, are made up of several distinct layers of cellular 
components including a thick muscular outer layer responsible for providing mechanical 
functions that support vascular dilation and contraction to regulate blood flow and 
pressure.  Veins, on the other hand, carry blood to the heart and are characterized by 
having thinner smooth muscle and connective tissues than arteries and one-way valves 
due to the lower fluid pressures that they encounter (Tucker & Bhimiji 2017).  The 
smallest structures in the blood vascular system are capillaries which consist of a single 
layer of endothelial cells and perivascular support cells known as pericytes. These 
capillaries, together with arterioles and venules, constitute the microvascular system and 
primarily serve to regulate the physiological homeostasis of all tissues (Sumagin & 
Sarelius 2014).  To maintain tissue homeostasis, the vascular system functions to deliver 
oxygen and nutrients to cells, remove metabolic waste from the surrounding tissue, and 
provide routes through which immune cells can patrol for foreign materials. The 
endothelial cells that make up capillaries in particular play a critical role in these 
processes, as they form a direct semi-permeable barrier between blood and tissue through 




1.1.1 Molecular Players that Regulate Endothelial Barrier Function  
Given the importance of endothelial barrier function for maintaining tissue 
homeostasis, extensive research has investigated the various mechanisms through which 
endothelial cells tightly regulate their permeability.  Generally speaking, the semi-
permeable barrier generated by endothelial cells functions through two main pathways: 
the transcellular and paracellular routes.  Transcellular exchange of materials refers to the 
active transport of larger solutes through endothelial cells and is highly important for 
exchange of macromolecules like lipids and hormones.  Paracellular permeability, on the 
other hand, refers to passage of solutes through the intercellular space between 
endothelial cells and chiefly controls the passage of molecules such as glucose, ions, and 
water (Sukriti et al. 2014).  Though transcellular and paracellular permeability pathways 
work closely together to preserve physiological barrier, this section will focus its 
discussion exclusively on the endothelial cell-cell and cell-matrix interactions that 
regulate paracellular permeability.   
1.1.1.1 Cell-cell adhesion proteins  
Paracellular permeability of materials is tightly controlled by the ability for 
endothelial cells to maintain strong intercellular junctions that function to restrict the 
passage of albumin and other molecules greater than ~70kDa in molecular weight.  These 
size-selective intercellular junctions can be classified into two main types: adherens 
junctions (AJs) and tight junctions (TJs).  TJs are a particularly selective class of cell-cell 
junction composed of membrane proteins including occludin, claudins, and junctional 




with others of the same family on adjacent cells to form strong associations that prevent 
the passage of even very small molecules less than 1kDa in size and ions.  As such, TJs 
are poorly expressed in the microvasculature of many tissues and are mainly localized to 
organs that require exquisite control of molecular exchange like in the brain (Dejana et al. 
2009).  
AJs are the more commonly identifiable endothelial cell-cell junction and 
therefore found in most, if not all, microvascular beds.  While several proteins are present 
at AJs including platelet endothelial cell adhesion molecule and nectins, the most 
predominant molecular player within and marker of endothelial AJs is vascular 
endothelial cadherin (VE-cadherin).  VE-cadherin is a single-pass transmembrane protein 
consisting of five repeating extracellular cadherin domains that are responsible for 
establishing calcium-dependent homotypic bonds between cells.  In addition, VE-
cadherin molecules can form lateral cis-contacts that form larger adhesion complexes 
which help to strengthen these AJ-mediated cell-cell contacts.  Expression of VE-
cadherin has been shown to be critically important for proper embryo development, as 
loss of VE-cadherin or impairing functionality of VE-cadherin led to compromised 
development of vascular networks in mice and lethality past E9.5-E10 (Carmeliet et al. 
1999).  
Intracellularly, VE-cadherin has been recognized to bind with many classic 
cadherin superfamily-associated proteins that work in concert to establish barrier 
function.  Of note are the proteins within the catenin family: b-catenin, p120-catenin, and 




bind to the cytoplasmic domain of VE-cadherin, a-catenin only interacts with VE-
cadherin through binding to b-catenin.  In a resting and stable state, a-catenin is bound to 
b-catenin in a monomeric form and due to its conformation, cannot directly interact with 
F-actin.  Instead, a-catenin-binding proteins such as epithelial protein lost in neoplasm 
have been shown to link the intracellular VE-cadherin domain to the actin cytoskeleton 
(Chervin-Pétinot et al. 2012).  These stable cell-cell contacts are characterized by a linear 
VE-cadherin junction with thick cortical bundles of F-actin oriented parallel to the AJ.   
Previously, researchers have shown that various biomolecules are able to enhance 
barrier function through the stabilization of AJs. For example, sphingosine-1-phosphate 
(S1P), a lysophospholipid byproduct of sphingolipid metabolism, has been demonstrated 
to increase endothelial barrier function by inducing rapid polymerization of F-actin at the 
cell periphery and increasing VE-cadherin binding at cell-cell junctions (Wilkerson & 
Argraves 2014).  In other works, S1P’s function to diminish vascular permeability was 
linked to activity of proteins in the Rho GTPase family.  Particularly, Rac1 has been 
shown to be important in S1P-mediated barrier enhancement such that introduction of 
dominantly negative Rac1 into endothelial cells reduced the barrier enhancing effects of 
S1P (Xiong & Hla 2014).  In fact, others have also shown that Rac1 activation can 
directly increase cell-cell junction assembly (Daneshjou et al. 2015).  Interestingly, Rac1 
activation has also been linked to other mediators of barrier enhancement, including 
prostaglandin E2 (Birukova et al. 2007). 
1.1.1.2 Cell-matrix adhesion proteins 




found to regulate endothelial barrier function.  Generally speaking, cell-matrix adhesions 
are mediated through transmembrane receptors known as integrins.  Extracellularly, these 
integrins bind to a host of matrix proteins such as collagen I, laminin, and fibronectin.  In 
response to extracellular binding, integrins intracellularly recruit an assortment of 
proteins which complex together to form focal adhesion sites within the cell (Aman et al. 
2013).  These focal adhesion sites link with filamentous actin structures which constitute 
the cell cytoskeleton and in turn regulate cell shape and tension (Aman et al. 2013). 
  In the context of endothelial permeability, various integrins have been 
demonstrated to provide critical barrier stabilizing properties.  For instance, blocking of 
the α5b1 integrin using specific antibodies increases permeability and induces the 
formation of macroscopic intracellular gaps (Curtis et al. 1995, Lampugnani et al. 1991).  
In another study, treatment of endothelial monolayers with tumor necrosis factor α (TNF 
α), a known permeability inducing factor, has been shown to decrease cell-matrix 
adhesions by enhancing α5b1 integrin turnover (Gao et al. 2000).  Along the same lines, 
αvb3 has been implicated in maintaining barrier function.  Treatment with an αvβ3 
blocking antibody for example enhanced vascular leakage in response to permeability 
inducers like thrombin (Su et al. 2012).  However, there also exists evidence involving 
αvb3 in barrier disruption.  For instance, in lung endothelial cells, inhibition of αvb3 led to 
a reduction in vascular permeability after lung injury (Su et al. 2007).  
In addition to the integrins themselves, several focal adhesion proteins that 
intracellularly coalesce at traditional integrin-mediated adhesion sites have also been 




example, has been implicated in maintaining endothelial permeability.  In studies 
exposing endothelial cells to hyperosmolar solutions as a means of enhancing barrier 
resistance, mutations to FAK abrogated these permeability-reducing effects (Quadri et al. 
2003).   Paxillin, another focal adhesion protein that serves as a docking site for FAK, has 
been shown to localize to endothelial adhesions at the cell periphery in response to 
treatment with barrier-enhancing S1P (Shikata et al. 2003).  More recently, Huveneers et 
al. (2012) have demonstrated that vinculin, a focal adhesion protein that localizes to both 
cell-cell and cell-matrix adhesions, acts to resist the breakdown of AJs caused by 
thrombin. Based on these aforementioned findings, there is a growing hypothesis that 
cell-matrix adhesions at the cell periphery, mediated by focal adhesion proteins, help to 
counteract the dissolution of cell-cell adhesions that occurs upon stimulation with 
permeability inducing factors (Aman et al. 2013).   
  Intriguingly, these focal adhesion proteins have also been implicated in the 
disruption of endothelial barrier function in alternative contexts.  For example, mutations 
that inactivate FAK or treatment with FAK inhibitors have both been linked to barrier 
maintenance in response to stimulation with permeability-inducing factors (Chen et al. 
2012).  Along the same lines, when vinculin expression is silenced, the magnitude of 
barrier leakage caused by thrombin treatment is significantly reduced (Birukova et al. 
2016).  Thus, from these studies, it can be appreciated that the molecular players and 
signaling mechanisms involved in maintaining and disrupting barrier function highly 




1.1.2 Pathologies Involving Dysregulation of Endothelial Permeability  
 Prolonged dysregulation of endothelial barrier function has been recognized as the 
focal point of several debilitating pathological conditions.  For example, in diabetic 
retinopathy, the integrity of the blood-retinal barrier is compromised due to an increase in 
expression of VEGF (Gupta et al. 2013).  VEGF, which has been extensively studied in 
the context of new blood vessel development, has also been demonstrated to be a robust 
permeability factor and functions through myriad pathways to induce enhanced 
permeability including through increasing VE-cadherin intracellular phosphorylation and 
internalization (Gavard & Gutkind 2006).  
 In diabetic retinopathy and other pathological conditions such as sepsis, loss of 
proper barrier function leads to edema, the unchecked build-up of fluids in tissues, and 
can have severely detrimental effects.  For patients with diabetic retinopathy, this edema 
typically leads to impaired vision and eventual blindness (Boyer et al. 2013).  In septic 
patients, the shift in fluid distribution from the intravascular space to interstitial space 
caused by excessive inflammation of the vasculature may hasten organ function 
deterioration due in part to hypovolemia and poor vascular blood flow (Aird 2003). 
Given the importance of maintaining proper barrier function, establishing a more 
complex understanding how endothelial cells regulate their permeability functions in 
physiological and pathological settings will be critical to gaining insight into how we 




1.2 Endothelial Sprouting Angiogenesis 
 In addition to providing the necessary barrier function between blood and tissues 
to maintain tissue homeostasis, the vasculature is also responsible for meeting the 
demands of growing tissues in physiological settings.  This process of new blood vessel 
formation from existing vasculature, mainly capillaries, is known as angiogenesis.  
Postnatally, angiogenesis often occurs during muscular development, cyclical growth of 
the endometrium during the menstrual cycle, and wound healing.  Expansion of the 
vascular network through angiogenesis is especially important in these situations given 
the importance of oxygen and nutrient exchange and the diffusion limit of oxygen within 
tissues (100-200 µm) (Carmeliet & Jain 2000).   
Two distinct forms of angiogenesis have been identified: intussusceptive and 
sprouting.  Intussusceptive angiogenesis, also known as splitting angiogenesis, is a 
relatively recently uncovered mechanism first identified in the developing rat lung (Burri 
et al. 2004).  During this process, endothelial cells from existing vasculature create small 
invaginations into the capillary lumens.  New capillaries are formed when two 
invaginating points meet and fuse, thereby enhancing the complexity and surface area of 
the microvascular architecture.  Since the discovery of this phenomenon, it has been 
studied in greater detail in the context of zebrafish vascular plexus development and 
cerebral vascularization after focal ischemia in rats for example (Karthik et al. 2018, 
Zhang et al. 2002). 
Sprouting angiogenesis, on the other hand, is a more well-studied form of 




interstitial space (Figure 1.1). This process is driven by a host of microenvironmental 
cues but is largely controlled by the establishment of gradients of soluble factors from 
inflamed or hypoxic tissues (Carmeliet 2003).  In these settings, a variety of biochemical 
factors are presented to induce endothelial cells to escape their homeostatic state, 
breakdown their surrounding matrix, and migrate towards the chemoattractant gradient. 
Perhaps the most well-studied of these factors is VEGF, which has been discussed briefly 
in an earlier section of this dissertation in the context of vascular permeability and will be 
reviewed in greater detail in a later section of this chapter.  
Figure 1.1: The morphogenic steps involved in sprouting angiogenesis.  (A) Initiation 
of sprouting occurs in response to a gradient of angiogenic factors and begins by 
degradation of the endothelial basement membrane.  (B) The selected tip cell develops 
filopodia as it invades towards the source of angiogenic factors.  (C) Stalk cells follow 
the invading tip cell to form a multicellular, lumenized structure. One tip cell of a sprout 
can encounter another tip cell in order to form vascular connections. (D) Upon fusion and 
development of a flow-carrying neovessel, stabilization occurs through interactions with 





1.2.1 The Morphogenic Process of Sprouting  
 Upon initiation of sprouting angiogenesis via microenvironmental triggers such as 
VEGF, select endothelial cells within a quiescent capillary become activated into what 
are known as tip cells. These tip cells develop the ability to invade into the surrounding 
extracellular matrix through upregulation of expression of matrix metalloproteinases 
(MMPs) like MT1-MMP and must degrade the endothelial-derived basement membrane 
the process. This basement membrane, consisting of extracellular matrix proteins like 
laminin and collagen IV, has been shown to be physiologically important for maintaining 
endothelium quiescence and stability. For example, mice lacking expression of laminin-
211 in the brain were found to have significantly higher levels of vascular permeability 
and in in vitro settings, culture of brain endothelial cells on substrates coated with various 
basement components demonstrated improved barrier function (Menezes et al. 2014, 
Tilling et al. 1998). 
  Selection of cells into the tip cell phenotype leads to the subsequent assignment 
of stalk cell identity to the cells that follow the leader cell.  Whereas tip cells are known 
primarily for their proteolytic activity, these stalk cells are responsible for following 
closely behind the tip cells in order to create an intact multicellular vascular structure 
(Adams & Alitalo 2007).  In recent years, much research in the angiogenesis field has 
been devoted to uncovering the biological markers of tip and stalk cell identity and to 
understanding the process of establishing these sprouting phenotypes.  While many 
questions still remain regarding these aspects of angiogenesis, it is generally appreciated 




and Delta-like ligand 4 (Dll4), a Notch receptor ligand. Contrastingly, stalk cells exhibit 
greater levels of VEGF receptor-1 (VEGFR-1), a decoy receptor for VEGF, and Notch 
receptor activity (Blanco & Gerhardt 2013).  Though these molecular identifiers of tip 
and stalk cells have been established and will be discussed in greater detail in the 
subsequent section of this dissertation, recent work through the use of in vitro, in vivo, 
and in silico models have uncovered the intriguing ability for these tip and stalk cells to 
dynamically shuffle and compete for the leader cell position (Jakobsson et al. 2010).  
Additionally, as multicellular sprouts continue to invade into the surrounding tissue, 
stochastic changes in stalk cell expression levels of VEGFR-2 or local changes in levels 
of biochemical cues in the microenvironment have been shown to trigger stalk cells to 
transition into tip cells, thereby generating branched vascular structures (Blanco & 
Gerhardt 2013).  For example, in a mouse retina model of angiogenesis where the 
physiological distribution of the VEGF gradient was altered, abnormal development of 
new tip cells was observed (Gerhardt et al. 2003).   
 Though the initiation and subsequent growth of angiogenic sprouts are important 
stages in forming new vasculature, a variety of other processes must occur in order for 
these nascent sprouts to form patent vessels capable of transporting blood. For example, 
new capillary sprouts must find and connect with other capillaries through a process 
known as anastomosis in order to form a closed circuit in the microcirculatory network.  
Interestingly, much of the research surrounding mechanisms that facilitate anastomosis 
involve participation from non-endothelial cell types. As an example, macrophages can 




macrophages to the developing brain led to a reduction in capillary network complexity 
(Fantin et al. 2010).  Following anastomosis, neovessels undergo additional steps to attain 
stability.  This includes the recruitment of pericytes by endothelial-derived platelet-
derived growth factor-b (PDGF-b) as well as additional deposition of basement 
membrane proteins (Bergers & Song 2005).  
1.2.2 Soluble Factors Involved in Angiogenesis 
 Given the highly complex nature of angiogenesis, it is not surprising that various 
soluble factors have been implicated in driving angiogenic sprouting.  Over the past 
several decades, VEGF has been given substantial responsibility for coordinating this 
morphogenic process.  Nonetheless many other growth factors and cytokines have been 
demonstrated to play essential roles in the different phases of angiogenesis, including 
sprout initiation and maturation.  This section will describe the functions of VEGF and 
some of these other soluble factors in greater detail. 
1.2.2.2 VEGF Signaling 
 The VEGF family of proteins includes seven members that are all share a 
common VEGF homology domain. While VEGF-A in particular plays a fundamentally 
critical role in sprouting angiogenesis, VEGF-B, VEGF-C, VEGF-D, VEGF-E, VEGF-F, 
and placental growth factor (PlGF) have been reported to possess other specialized 
functions (Hoeben et al. 2004).  VEGF-B, for example, is prominently expressed in adult 
heart tissue and embryonic fat and muscle. In vivo, it has been shown to regulate fatty 
acid shuttling and energy metabolism (Li 2010).  VEGF-C has been found to be 




of inducing growth of the lymphatic vessels through lymphangiogenesis, particularly 
during cancer progression (Hoeben et al. 2004).  
 VEGF-A in particular exists in a multitude of different isoforms, including 
VEGF-A121, VEGF-A165, and VEGF-A189 (Nakatsu et al. 2003).  While these different 
isoforms of VEGF-A have some redundant functions, they have also been shown to have 
varied properties and impact on vessel formation.  For instance, VEGF-A121 have been 
shown to increase vessel diameter whereas VEGF-A189 has the opposite effect (Nakatsu 
et al. 2003, Carmeliet 2000).  VEGF-A165 and its mouse-specific counterpart VEGF-A164 
have especially taken a central role in guiding various aspects of angiogenesis.  In a 
variety of different physiological and pathological contexts, this form of VEGF-A 
induces robust migration of endothelial cells, branching of vascular structures, and 
formation of perfusable sprout structures (Kawamura et al. 2008, Romano di Peppe et al. 
2002, Grunstein et al. 2000). 
 Intriguingly, the specific isoform of VEGF-A is not the only determinant of 
sprout morphogenesis; the receptor that VEGF-A binds to also has been shown to play a 
critical role on endothelial cell behavior.  Of the three VEGF receptors, VEGFR-1 and 
VEGFR-2 bind with VEGF-A.  VEGFR-1 exists in both a soluble (sVEGFR-1) and 
membrane-tethered (mVEGFR-1), whereas VEGFR-2 is strictly a cell-surface receptor 
and transduces most of the pro-angiogenic properties of VEGF in endothelial cells 
(Shibuya 2011).  Paradoxically, VEGF-A binds to both forms of VEGFR-1 with ten-fold 
greater affinity than VEGFR-2 yet exhibits very low levels of intracellular kinase 




inhibition of VEGFR1 activity does not severely impact sprouting within the developing 
retina (Gerhardt et al. 2003). In spite of this low activity, loss of VEGFR-1 during 
development still leads to aberrant formation of the vasculature, causing embryonic 
lethality (Meyer et al. 2005).  In its soluble form, VEGFR-1 is also thought to help 
establish a negative feedback loop in order to keep VEGF signaling at an optimal 
balance, as stimulation with VEGF-A has been shown to upregulate expression of 
sVEGFR-1 in endothelial cells (Saito et al. 2013).  All in all, these intricacies of VEGF 
receptor binding and the multitude of forms in which VEGF exists generate a complex 
mechanism through which VEGF signaling impacts sprouting angiogenesis.  
1.2.2.3 Other Chemical Drivers of Signaling  
The superfamily of fibroblast growth factors (FGFs) has also been highly studied 
in the context of angiogenesis, particularly since it was the first pro-angiogenic molecule 
identified in the early 1980s (Cross & Claesson-Welsh 2001).  In in vitro studies of 
angiogenesis, FGF-2 specifically has been shown to enhance cellular functions in 
endothelial cells that are critical for sprouting, including proliferation, migration, and 
proteinase expression.  Incidentally, signaling pathways involving FGF and VEGF have 
been linked.  For instance, upon stimulation with FGF-2, expression of VEGF in 
endothelial cells increased (Seghezzi et al. 1998).  In vivo, co-administration of FGF-2 
and VEGF led to an increase in mature vessel formation through enhancing endothelial-
mural cell interactions via the PDGF-b pathway (Kano 2005).  
Hepatocyte growth factor (HGF), also known as scatter factor, is also described as 




HGF can induce cell motility through the activation of migration-associated pathways 
involving protein kinase C and MAP kinase (Bussolino 1992, Cai et al. 2000).  Like FGF, 
HGF has also been shown to work synergistically with VEGF to mediate angiogenesis.  
For example, exposure to increasing concentrations of HGF enhanced the formation of 
endothelial tubular structures in the presence of VEGF at a fixed concentration.  In rats, 
dual growth factor exposure led to the most significant increase in neovascularization of 
the cornea (Xin et al. 2001).   
  Though VEGF, FGF, and HGF are among the most predominantly identified 
stimulators of angiogenesis, not all pro-angiogenic factors are growth factors.  S1P and 
prostanoids like prostaglandin E2 and prostaglandin I2 have demonstrated clear 
angiogenic properties (Takuwa et al. 2010, Hoang et al. 2015). S1P, a bloodborne lipid 
produced largely by red blood cells, in particular has demonstrated proliferative and 
migratory effects in endothelial cells in vitro and in vivo has proven to be important for 
vessel maturation through recruitment of pericytes and smooth muscle cells (Takuwa et 
al. 2010).  However, signaling through the S1P pathway is not always straightforward.  
Research has demonstrated that activation of different S1P receptors can have opposing 
outcomes.  For instance, while S1P stimulation through the receptor S1P1 has been 
linked to activation of cell migration through the Rho GTPase Rac, stimulation through 
S1P2 has been led to an inhibitory effect of Rac activity (Takuwa et al. 2010).  These 
results together highlight the complex role of signaling molecules in angiogenesis and 





1.2.3 Cell-cell Coordination during Sprouting Angiogenesis 
 As with many other forms of tissue development, angiogenesis is a coordinated, 
multicellular morphogenic process.  Coordination among endothelial cells during this 
process is of particular importance, given that these cells must remain physically intact in 
order to form patent, lumen structures capable of forming an efficient network for 
carrying blood flow.  Endothelial cells invoke two prominent methods of maintaining 
cell-cell coordination during sprouting, namely through the Notch signaling pathway and 
through the cell-cell adhesive molecule VE-cadherin. 
1.2.3.1 Role of Notch Signaling  
As was previously eluded to, the Notch signaling pathway has taken center stage 
in the research surrounding endothelial cell-cell coordination during angiogenesis.  
However, long before its study in the context of angiogenesis, research focused on 
Notch’s role during development.  Notch signaling was first discovered during studies of 
mutant Drosophila presenting aberrantly notched wings (Siebel & Lendahl 2017).  Since 
then, Notch signaling has been implicated in many other developmental processes like 
boundary formation of tissues.  For instance, the Notch pathway is used by two 
embryonic epithelial cell types in order to generate two distinct sides of the dorsal 









The precise and complex mechanisms by which Notch regulates cell-cell 
communication has been extensively investigated. But generally speaking, Notch 
signaling occurs between two cells through the complementary expression of Notch 
receptors and Notch ligands (Figure 1.2).  In mammals, four Notch receptors (Notch 1-4) 
and two classes of ligands (Delta-like and Jagged) have been identified. When a receptor-
presenting cell is juxtaposed to a ligand-presenting cell, engagement of the receptor 
triggers cleavage of the Notch extracellular domain (NECD) of the receptor by the 
protease ADAM10.  This event is followed by cleavage of the Notch intracellular domain 
(NICD) by the enzyme g-secretase. The newly freed NICD is then able to translocate into 
Figure 1.2: The central stages of the Notch signaling pathway.  Upon Notch receptor 
activation in a cell via binding to the ligand Delta, two proteolytic cleavage events occur. 
The first is mediated by ADAM10 and releases the extracellular domain of Notch. The 
second cleavage event occurs intracellularly via γ-secretase.  Upon release, the 
intracellular domain of Notch is transported to the nucleus, where it complexes with 
other transcription factors and DNA-binding proteins to induce target gene expression. 




the nucleus, where it engages in a transcriptional complex with other factors like the 
adaptor protein Mastermind-like to regulate expression of downstream genes.  In the 
ligand-presenting cell, the ligand-NECD complex is then internalized for recycling 
(Kopan 2012).  
As previously described, in the context of angiogenesis, Notch is most well-
known for specifying tip and stalk cell identity (Figure 1.3).  Typically, in a quiescent 
capillary, endothelial cells display mosaic patterning of Notch 1-expressing cells and 
Dll4-expressing cells.  During angiogenesis, stimulation with VEGF-A is thought to 
increase transcriptional expression of Dll4 and activate the tip cell phenotype.  The rise in 
ligand presentation from this cell stimulates Notch receptor signaling in its neighboring 
cells, which can lead to repression of VEGFR-2 expression, thereby desensitizing these 
cells from stimulation by VEGF.  In addition, these cells exhibit an increase in expression 
of VEGFR-1, a decoy receptor for VEGF-A, that further helps to diminish impact of 
VEGF-A.  These feedback loops thus work in concert to help stabilize the tip-stalk 





The importance of this lateral inhibition effect imparted by Notch signaling is 
highlighted in studies that perturb the Notch pathway during angiogenesis.  For instance, 
when Notch signaling was globally inhibited across the entire population of endothelial 
cells through genetic mutations or treatment with g-secretase inhibitors, an increase in tip 
cell frequency and hypersprouting were observed.  Contrastingly, when Notch receptor 
activity was broadly enhanced through treatment with a soluble Jagged1 ligand, the 
number of tip cells was markedly reduced (Hellstrom et al. 2007).  Indeed, from these 
studies, it is evident that Notch-mediated cell-cell communication is highly critical for 
achieving proper sprout morphogenesis.  
Figure 1.3: Tip and stalk cell selection via Notch signaling.  In response to a gradient 
of angiogenic factors like VEGF, expression of Dll4 becomes upregulated in the leading 
tip cell.  This in turn leads to enhanced Notch receptor signaling in the following stalk 
cell, which has been shown to led to reduction in VEGFR2 expression.  (Modified from 




1.2.3.1 Role of VE-cadherin  
As was previously stated, VE-cadherin is a transcellular molecule known the 
regulate endothelial cell-cell adhesiveness and barrier formation both in vitro and in vivo.  
Thus, it is not surprising that VE-cadherin also holds a vital role in sprouting 
morphogenesis.  In mice embryos which lack VE-cadherin, angiogenesis and subsequent 
remodeling of the vascular network are severely limited.  The resulting network is 
characterized as fragmented and unstable, with cells detaching from their basement 
membrane layers and forming large gaps between themselves (Carmeliet et al. 1999).  
Intriguingly, however, VE-cadherin has been shown to be dispensable for the initial 
formation of a primitive vascular network.  This corroborates the notion that VE-
cadherin’s role in blood vessel development is of utmost significance during the active, 
dynamic stages of endothelial cell morphogenesis (Carmeliet et al. 1999, Crosby et al. 
2005). 
In order to support active rearrangement and remodeling of cells, VE-cadherin 
directly interacts with and modulates the cellular cytoskeleton.  For example, in cases 
where VE-cadherin is modified to disrupt its ability to interact with the actin 
cytoskeleton, through mutation of its b-catenin binding domain for example, sprouting 
and collective endothelial cell migration are severely abrogated (Carmeliet et al. 1999, 
Oubaha et al. 2012).  Loss of VE-cadherin has also been shown to cause changes in cell 
shape and disorganization of the cytoskeleton structure.  This was attributed to VE-
cadherin’s role in activating Rac1 through the recruitment of the Rac-specific guanine 




In addition to orchestrating critical, cytoskeleton-associated functions, VE-
cadherin also regulates an assortment of non-cytoskeletal related angiogenesis events.  
Through interactions with the polarity protein Pals1, VE-cadherin enables the formation 
of lumen structures (Brinkmann et al. 2016).  In the development of vasculature in the 
zebrafish, VE-cadherin allows the proper anastomosis of new sprouts to existing vessels 
(Lenard et al. 2013).  And in relation to VEGF signaling, which is regarded as the main 
growth factor signaling pathway driving angiogenesis, VE-cadherin intriguingly 
suppresses VEGFR-2 internalization (Lampugnani et al. 2006).  However, upon 
stimulation with VEGF, VE-cadherin is subsequently phosphorylated and internalized 
(Dejana et al. 2008).  Taken together, these studies reflect the central and multi-faceted 
roles that VE-cadherin holds in regulating various aspects of endothelial cell-cell 
communication during angiogenesis.   
1.2.4 Cell Mechanics and Extracellular Matrix Cues in Sprouting Angiogenesis 
As with many morphogenic processes, angiogenesis involves active, coordinated 
migration of cells into three-dimensional (3D) space.  As such, this process highly 
depends on the ability for cells to engage their motility machinery as well as integrate 
external mechanical cues imparted by the surrounding ECM.  This section will highlight 
some of the key players that regulate cell migration during angiogenesis and discuss the 
impact of ECM properties on sprout morphogenesis.  
1.2.4.1 Molecular Regulation of Cell Mechanics during Angiogenesis 
It is well-established that mechanical forces generated by cells are crucial for 




is the Rho-family of small GTPases.  These factors have been found to also regulate an 
incredibly diverse set of cellular functions including cell polarization, apoptosis, and 
membrane transport to name a few (Bryan & D’Amore 2007).  Among the many proteins 
that fall within the Rho GTPase family, RhoA, Rac1 and Cdc42 perhaps have been 
studied to the greatest extent.   
In the context of angiogenesis, these proteins have been described to control 
unique aspects of sprout morphogenesis.  For instance, RhoA, which in single cell studies 
has been shown to promote tail retraction during cell migration, has been linked to 
enhancing 3D invasion of endothelial cells in response to VEGF stimulation (van Nieuw 
Amerongen et al. 2003).  In other studies, overexpression of RhoA was linked to an 
increase in ability for endothelial cells to form multicellular, tubular structures (Zhao et 
al. 2006, Hoang et al. 2004).  However, the role of RhoA in sprouting is not necessarily 
straightforward.  While these studies pinpoint RhoA as a positive regulator of 
angiogenesis, other studies indicate opposing results.  For example, using in vitro and in 
vivo models of angiogenesis, Kroll et al. (2009) found that pharmacological inhibition of 
downstream effectors of RhoA led enhanced sprouting in response to VEGF. 
While RhoA is classically seen as a regulator of cell contractility, Rac1 is known 
to regulate actin polymerization into broad lamellipodia-like structures at the leading 
front of migrating cells (Bryan & D’Amore 2007).  As such, Rac1 has predominantly 
been implicated in the homeostatic maintenance of endothelial cell-cell contacts and 
barrier function (van Buul & Timmerman 2016).  However, in regard to angiogenesis, 




morphogenesis during development.  For example, in vitro, loss of Rac1 in endothelial 
cells has been linked to inefficient network formation and lumen formation (Koh et al. 
2008).  In mice with endothelial-specific deletion of Rac1, vascular network complexity 
was compromised as measured by vascularized area and number of branch points.  
Intriguingly, it was also found that at the sprouting front of developing retinas, loss of 
Rac1 also led to a reduction in the number of identifiable tip cells (Nohata et al. 2016).   
Cdc42, another important regulator of actin dynamics in 2D cell migration, has 
also been demonstrated to dictate important aspects of angiogenesis, although it has not 
been studied in the context of sprouting as much as RhoA and Rac1 have been 
investigated.  Especially given the critical role of Cdc42 in the formation of filopodia, 
which are small finger-like actin protrusions thought to help cells probe the surrounding 
microenvironment, it is not surprising that vascular area in the development retina was 
abrogated with the loss of Cdc42 expression. This was accompanied by a reduction in 
branch points in the vascular plexus as well as diminished filopodia formation in tip cells, 
suggesting Cdc42’s critical role in forming an efficient vascular network (Sakabe et al. 
2017).  Incidentally, Cdc42 has been shown to execute some morphogenic functions 
similar to that of Rac1. Specifically, loss of Cdc42 was also associated with a reduction 
in multicellular tube formation and lumen formation (Koh et al. 2008).  
Many aspects of cell migration and cytoskeletal rearrangement not only depend 
on the Rho-GTPases but also on the critical motor protein non-muscle myosin II (NMII). 
NMII is an ATP-driven molecular motor that crosslinks filamentous actin structures in 




that drive translocation and productive cell migration (Vicente-Manzanares et al. 2009).  
In migrating cells, NMII performs several different critical functions.  At the trailing edge 
of a cell, NMII has been shown to integrate into strong actin filaments to provide 
retraction of the cell body, thereby enabling forward cell movement (Kolega 2003).  
NMII also localizes to actin filaments anchored at growing sites of integrin-mediated 
substrate adhesions.  At these locations, NMII is thought to both crosslink actin filaments 
and also provide enough mechanical force to unravel cryptic binding sites of key 
intracellular focal adhesion components like talin.  Enhanced association of additional 
adhesion proteins at these new binding regions in turn can strengthen overall linkage of 
cells to the ECM, thereby regulating motile capacity (Burridge & Guilluy 2016).  This 
effect is thought to be biphasic such that there is an optimum focal adhesion size that 
enables maximal migration speed and increases to adhesion area beyond this optimal size 
reduces rate of cell migration (Kim & Wirtz 2013).   
Three dominant isoforms of NMII have been identified (NMIIA, NMIIB, NMIIC) 
and are distinguished by differences in their heavy chain component.  More recently, 
research in this field has focused on distinguishing the functions of these isoforms, with 
particular emphasis on NMIIA and NMIIB.  In various cell types, spatial localization of 
NMIIA and NMIIB are distinct.  NMIIA for example is seen to localize primarily to the 
leading front of a migrating cell and integrates into transverse arc stress fibers. NMIIB 
however has been frequently found to co-localize with actin stress fibers particularly in 
the retracting tail of a migrating cell (Jorrisch et al. 2013; Hindman et al. 2015; Kuragano 




from these studies together emphasize the importance of NMII isoforms in determining 
front-rear cell polarity, highlighting yet another aspect of cell migration that is highly 
dependent on NMII function.  
Despite our growing understanding of NMII functions, the role of NMII 
specifically in the context of angiogenesis has yet to be clearly defined.  For example, 
Rho and ROCK, two upstream regulators of myosin-mediated contractility have been 
shown to positively regulate VEGF-mediated angiogenesis and endothelial cell-cell 
junction integrity (Bryan et al. 2010).  However, in alternative studies, others have shown 
that blocking cell contractility through ROCK inhibition leads to diminished angiogenic 
potential of endothelial cells (Uchida et al. 2000).  These conflicting findings may in part 
be due to the different contexts in which angiogenesis has been studied (i.e. in 2D 
settings versus 3D settings; with global exposure to angiogenic factors versus exposure to 
a gradient of stimulants) as well as the non-targeted approaches used to manipulate NMII.   
1.2.4.1 Impact of Extracellular Matrix Properties on Sprouting 
 Though much of the discussion regarding drivers and regulators of angiogenesis 
thus far have revolved around soluble chemical factors and cellular proteins, the ECM 
and its various properties also hold critical importance in dictating neovessel formation.  
In particular, ECM composition and stiffness have been identified as key modulators or 
sprouting morphogenesis.  
 Many of the numerous identified ECM proteins have been studied to some extent 
in the context of angiogenesis, but fibronectin, collagen IV, and laminins have perhaps 




possess broad pro-angiogenic properties (Sottile 2004).  In vitro, impeding particular cell-
adhesive moieties of fibronectin through treatment with blocking antibodies led to a 
significant reduction in the ability for endothelial cells to adhere to substrates and form 
network-like structures.  This effect was validated in vivo in models of both physiological 
and pathological angiogenesis (Kim et al. 2000).  In another study, it was suggested that 
local secretion of fibronectin by endothelial cells encourages cellular cohesiveness, as 
evidenced by an increase in single cell motility and reduction in capacity to form 
multicellular tube structures when endogenous fibronectin expression was knocked down 
(Cseh et al. 2010). These results together suggest that fibronectin derived from the 
stromal component as well as endothelial-derived fibronectin may both hold critical roles 
in creating a pro-angiogenic microenvironment.  
On the other hand, collagen IV and laminins, major components of the endothelial 
basement membrane, have been shown to possess both pro- and anti-angiogenic 
properties depending on its presented form.  For example, in its intact form, collagen IV 
has been shown to promote sprout elongation and long-term vessel stabilization 
(Bonanno et al. 2000).  However, endothelial cells cultured on the fragment of collagen 
IV arresten were less proliferative and less effective at forming multicellular network 
structures and in vivo, arresten significantly restricted vessel formation (Colorado et al. 
2000).  In the case of laminins, the a and b subunit chains that together make up an intact 
laminin isoform have demonstrated some opposing effects on angiogenesis as well.  
While various a chains have predominantly enhanced endothelial cell migration and tube 




formation (Simon-Assmann et al. 2011).  In contrast, other studies investigating effects of 
intact laminin proteins like laminin-1 and laminin-8 suggest broad pro-angiogenic effects 
(Li et al. 2006, Ponce et al. 2003, Dixelius et al. 2004).  Overall, these studies contrasting 
the roles of ECM molecules, especially those that are composed of different 
subcomponents and exist in multiple isoforms, highlight the complexity of angiogenesis 
and the importance of investigating the variety of factors that may regulate different 
stages of sprout morphogenesis.  
  In addition to matrix composition, mechanical and biophysical properties of the 
ECM have demonstrated significant ability to dictate sprouting morphogenesis.  Matrix 
density or matrix concentration, for instance, has been modulated in various in vitro 
models of angiogenesis.  Increasing the density of collagen I has been shown to enhance 
the number of cells within a neovessel while simultaneously reducing sprout length; this 
effect was attributed to an increase in vessel diameter (Shamloo & Heilshorn 2010).  
Intriguingly, though increasing matrix density reduced sprouting speed, it also led to a 
rise in the number and length of small filopodia-like structures in tip cells (Abbey & 
Bayless 2014).  The specific cause of this change is unclear but may be attributed to 
alterations in matrix porosity and/or an increase in presentation of adhesive moieties that 
typically accompany changes in matrix concentration.   
Since changing collagen density also alters a multitude of other matrix properties, 
research groups have taken advantage of methods to modulate various aspects of the 
ECM independent of concentration.  Matrix stiffness in particular is one of these 




tend to be stiffer than normal tissues and also harbor aberrant vasculature.  Indeed, 
Bordeleau et al. (2017) found that glycating collagen through treatment with ribose 
increased the stiffness of the matrix and this increase in stiffness led to enhanced 
endothelial sprouting and vascular branching.  Along the same lines, diminishing matrix 
stiffness in vivo through prevention of collagen crosslinking via lysyl oxidase reduced 
vascular network formation in breast tumors (Bordeleau et al. 2017, Shi et al. 2018).   
Together, the aforementioned studies and many others emphasize the incredibly 
complex nature of angiogenic sprouting.  Integration of chemical and mechanical cues as 
well as a wide variety of signaling pathways are essential to enabling the key cell-cell and 
cell-matrix interactions that are necessary for proper sprout formation.  Generating a 
more comprehensive understanding of the molecular players involved in angiogenesis 
will be critical for enabling researchers to recapitulate physiological sprouting 
angiogenesis in the context of tissue engineering and regenerative medicine, for example. 
 
1.3 Pathological Involvement of Vasculature in Cancer 
Given the paramount importance of proper vascular barrier and angiogenesis in 
maintaining tissue homeostasis, it is not surprising that many pathological conditions 
involve the dysregulation of these functions. For example, in a previous section of this 
chapter, diabetic retinopathy was discussed in the context of vascular hyperpermeability. 
In fact, this condition is also characterized by inducing abnormal angiogenesis of the 
vasculature within the retina especially during more advanced stages of the disease.  




and hyperpermeability of these new vessels can hasten disease progression and 
drastically increase chances of hemorrhage and vision loss (Crawford et al. 2009). In 
other cases, dysregulation in the form of abnormal vessel regression or inadequate 
angiogenesis are seen in cases of osteoporosis, diabetic neuropathy, and nephropathy to 
name a few (Carmeliet 2003). However, aberrant angiogenesis is perhaps most notably 
studied in the context of cancer progression and metastasis after seminal work by Judah 
Folkman where he first hypothesized the importance of vascularization to support a 
tumor’s unchecked growth (Folkman 1971).  
1.3.1 Angiogenesis in Cancer 
Tumor angiogenesis has been named one of the six original hallmarks of cancer 
first defined by Hanahan and Weinberg (2000).  As with normal tissues, tumors require 
adequate oxygen and nutrient supply in order to continue proliferation. As neoplasms, 
initiating tumors are therefore often hindered in growth and instead enter into a balance 
of cell proliferation and cell death due to the inability to recruit new vasculature (Ribatti 
et al. 2007). However, as tumors develop more biological mechanisms to replicate 
uncontrollably and become more genetically unstable, cancerous cells trigger an 
“angiogenic switch” (Ribatti et al. 2007).  This process is characterized by an enhanced 
expression of proangiogenic factors like VEGF from the tumor as well as repression of 
endogenous anti-angiogenic factors such as thrombospondin-1.  When this shift in 
balance occurs, the gradient of pro-angiogenic factors generated by the tumor can 






While the process of tumor angiogenesis seems conceptually similar to 
physiological sprouting angiogenesis, features of the resulting neovasculature are 
strikingly distinct. Specifically, due to the drastic shift in balance between pro-angiogenic 
and anti-angiogenic factors, new capillary structures often fail to reach a quiescent 
equilibrium. This is accompanied and/or exacerbated by a breakdown in association 
between endothelial cells and their support pericytes (Barlow et al. 2013).  As a result of 
these pathological changes, the tumor vasculature is often characterized as being highly 
dilated, tortuous, and less effective in making proper anastomoses to generate functional 
networks (Jain 2005).  
Nonetheless, vasculature has also been demonstrated to be particularly important 
for providing cancers access to the blood circulatory system in order to escape to and 
grow in other sites and organs.  This process of metastasis is of significant importance in 
the study of cancer progression since the majority of cancer-related deaths can be 
attributed to the formation of metastases (Mehlen & Puisieux 2006).  To begin down the 
Figure 1.4: Different modes of tumor vascularization and tumor-endothelial cell 
interactions.  (A)  Endothelial sprouting occurs in response to a variety of soluble and 
insoluble microenvironmental factors.  (B)  Vasculogenic mimicry involves the 
development of perfusable, vessel-like structures that do not exclusively consist of 
endothelial cells but may also be formed by tumor cells.  (C)  Vascular co-option is the 
process by which cancer cells invest in the perivascular niche as an alternative to 




metastatic cascade, cancer cells must first acquire the capability to break away from the 
primary tumor site and navigate through the surrounding tissue (Hanahan & Weinberg 
2000).  Classically, this process involves the enhanced ability for cancer cells to adhere to 
and degrade extracellular matrix (ECM) components such as collagen using MMPs. 
Alternative methods of cancer cell migration have also been identified.  In a context-
dependent manner, some cancer cells can move in an amoeboid fashion in which matrix 
degradation and adhesion are not necessary (Friedl & Wolf 2010).  Once tumor cells are 
able to escape from their original site, they must gain access to the systemic circulation 
by breaking through the endothelial basement membrane, survive within the circulatory 
system, arrest at a distant site, and extravasate from the circulation into a new tissue. 
Each of these steps in the multistage process of metastasis provides their own unique sets 
of challenges. For example, only a small fraction of tumor cells that shed into the 
circulation are able to survive and form metastases due to active immune surveillance as 
well as the harsh fluidic shear stresses imposed by circulating blood.  Once cancer cells 
are able to extravasate from the circulation, they must readapt to the new host tissue and 
regain the capability to proliferation and stablish new vasculature (Wirtz et al. 2011).  
Given the importance of the vasculature in potentiating tumor growth and 
malignancy, treatment options for targeting tumor-associated vessels have long been 
pursued.  The most common approach involving this strategy has been to develop 
therapeutics targeting the VEGF signaling pathway.   In particular, many VEGF-
sequestering antibodies and anti-VEGF receptor inhibitors have been developed with the 




anti-VEGF therapeutics have demonstrated limited success in the clinic especially with 
regard to breast, pancreatic, and prostate cancer as well as melanoma (Ribatti 2016).   
Subsequent studies investigating mechanisms involved in refractory responses to anti-
VEGF treatments have uncovered several means by which these tumors can persist 
(Bergers & Hanahan 2008).  In some cases, tumors have been shown to actively 
circumvent anti-angiogenesis therapeutics.  For example, in pancreatic cancer, tumors 
treated with anti-VEGFR treatments demonstrated an increase in expression of other pro-
angiogenic factors such as fibroblast growth factor-1 and angiopoietin-1 (Casanovas et al. 
2005). And in a mouse model of glioblastoma multiforme (GBM), treatment with the 
VEGF inhibitor semaxanib caused tumors to establish smaller satellite tumors that 
extended the malignant margins of primary tumors (Rubenstein et al. 2000).  In other 
cases, tumors have demonstrated indifference to anti-angiogenic drugs.  This effect was 
highlighted in a study of various types of cancer (e.g melanoma and lung carcinoma), 
which found that recruitment of immune cells by tumors rendered anti-VEGF treatments 
ineffective (Shojaei et al. 2007).   
Despite these unexpected treatment outcomes, anti-VEGF therapies have 
paradoxically gained utility as cancer treatments when combined with a variety of other 
chemotherapeutic agents (Goel et al. 2011).  This combination treatment strategy owes its 
success to the ability for anti-VEGF therapies to normalize the leaky and inefficient 
nature of tumor-associated vessels, thereby improving delivery of other more effective 
cytotoxic agents.  For example, tumor oxygenation improved in models of melanoma, 




inhibitors have been effective in improving oxygenation of tumors in models of 
squamous carcinoma and fibrosarcoma (Goel et al. 2011).  Others have directly shown 
that administration of anti-VEGF antibodies in tumor-bearing mice led to significant 
reduction in vascular permeability (Yuan et al. 1996, Litchenbeld et al. 1999). 
Though anti-VEGF treatments may be efficacious in certain settings, recent 
studies highlight some of the detrimental effects of discontinuing anti-VEGF regimens.  
As an example, in 2009, Ebos et al. found using a mouse model of breast cancer that 
short treatments with the VEGFR inhibitor sunitinib actually accelerated metastasis and 
markedly decreased overall survival.  Along the same lines, Yang et al. (2016) recently 
discovered that discontinuation of anti-VEGF antibody treatment led to enhanced liver 
metastasis in a mouse model of colorectal cancer.  Together, these data contrasting the 
efficacy and counterproductive effects of anti-angiogenesis therapeutics highlight the 
complexity of tumor angiogenesis and the need to more closely elucidate molecular 
players and mechanisms of action involved in physiological and pathological 
angiogenesis. 
1.3.2 Vascular Mimicry and Vascular Co-option 
Through the field’s extensive investigation into mechanisms by which tumors can 
evade or bypass anti-VEGF treatments, new ways in which tumors interact with the 
vascular system have become identified and more thoroughly researched (Figure 1.4B). 
Vascular mimicry (VM) in particular has emerged as an alternative form of 
vascularization for tumors, though it does not involve participation of true endothelial 




network-like structure within the tumor.  These capillary bed-like networks are lined with 
tumor cells that often display de-differentiated characteristics and altered gene expression 
profiles.  In some cases of VM, the cancer cells lining “vessel” structures even displayed 
classic markers of endothelial cells including VE-cadherin, CD34, and CD31 (Dunleavey 
& Dudley 2014).  Despite the lack of bona fide endothelial cells, these structures are 
capable of carrying blood flow and thus are likely to have points of anastomosis with the 
host vascular system.  Intriguingly, in several studies, it has been demonstrated that VM-
displaying tumors express anticoagulant factors such as tissue factor pathway inhibitors 
1, suggesting that these tumors have been programmed to enable blood flow through the 
cancer-derived vessel-like structures (Ruf et al. 2003).  Though the VM phenomenon was 
hotly debated and met with great skepticism during the years following its first 
observation, it has now been studied in a variety of cancer cell types including cutaneous 
melanoma, breast cancer, and lung cancer (Dunleavey et al. 2014).  Given the growing 
clinical evidence connecting VM with poor prognosis and metastasis, more research to 
understand the drivers and signaling pathways behind VM are needed.  
Vascular co-option, when tumors commandeer existing blood vasculature as an 
alternative to inducing angiogenesis, has also emerged as a strategy employed a variety of 
cancer types (Figure 1.4C). This phenomenon was first studied in detail in the brain, 
which is a highly vascularized and oxygenated organ (Donnem et al. 2013).   For 
instance, in a mouse model of glioma, researchers found co-option events occurring as 
early as one week after implantation of cancerous cells.  Contrastingly, angiogenesis 




weeks after implantation (Zagzag et al. 2000).  Intriguingly, vascular co-option has been 
implicated in tumor resistance to anti-angiogenesis treatments. In a rat model of GBM, 
anti-VEGF treatment enhanced vascular association of cancer cells (Rubenstein et al. 
2000).  Similarly, in an orthotopic mouse model of hepatocellular carcinoma, treatment 
with the VEGFR inhibitor sorafenib led to more extensive cancer invasiveness and 
vascular co-option (Kuczynski et al. 2016). 
In spite of the described differences between tumor angiogenesis and vascular co-
option, mechanisms that are involved in vessel co-option have been investigated to a 
much lesser extent as compared to angiogenesis.  Recently, a few research groups have 
begun to delve deeper into the molecular players that are involved in mediating cancer-
endothelial interactions. For example, Carbonell et al. (2009) studied breast cancer and 
melanoma in a model of brain metastasis and found that direct association of cancer cells 
to the vasculature was mediated by integrin b1.  In fact, pre-treatment with an integrin-
blocking antibody was able to reduce the ability for cancer cells to interact with vessels 
and to expand in volume.  In another study using a brain metastasis model of melanoma, 
researchers found that endothelial expression of Serpin B2 may facilitate vascular co-
option (Bentolila et al. 2016).  Developing a more complex understanding of the 
molecular players of this phenomenon may be critical to establishing a more complete 
understanding of ways in which treatments can be designed to impede tumor-vasculature 




CHAPTER 2:  THE ROLE OF NOTCH SIGNALING IN ENDOTHELIAL CELL 
CONTRACTILITY 
Introduction 
 The endothelial lining of blood vascular structures provides a semi-permeable 
membrane across which transport of fluid, ions, solutes, and immune cells can occur 
between the circulation and surrounding tissues (Sukriti et al. 2013).  Proper preservation 
of this endothelial barrier is critical for maintaining tissue homeostasis, and dysfunction 
of vascular permeability is often linked to pathological conditions like diabetic 
retinopathy and sepsis (Boyer et al. 2013, Aird 2003).  Given the importance of proper 
endothelial permeability and the detrimental consequences of compromised barrier 
function, investigation into the various mechanisms that dictate the physiological and 
pathological properties of the endothelium have been extensively investigated.  Particular 
interest has been given to the regulation of endothelial cell-cell contacts, which determine 
the paracellular permeability of the endothelium and are dynamically controlled by a 
variety of cell-cell and cell-matrix regulators (Sukriti et al. 2013).   
 The mechanical activity of endothelial cells has been identified as a large 
contributor to the permeability status of endothelial monolayers.  Under inflammatory 
conditions, through exposure to soluble factors such as TNFα and histamine, increases in 
paracellular permeability have been attributed to enhanced myosin-based contractility 
and activation of RhoA (Petrache et al. 2001, Wójciak-Stothard et al. 2001).  However, 
evidence from a collective of previously published works demonstrates the need for an 




al. 2015).  For example, in van Nieuw Amerongen et al. (2007), the authors demonstrate 
that treatment with the Rho kinase inhibitor Y-27632 leads to increases in baseline 
permeability measurements.  Similarly, exposure to blebbistatin, an inhibitor of non-
muscle myosin II, and NSC23766, an inhibitor of Rac1, both led to significant reductions 
in endothelial barrier function (Breslin et al. 2015, Baumer et al. 2009).  In both cases, 
whether permeability is increased due to underactive or overactive cell contractility, VE-
cadherin-based cell-cell adhesions are also compromised (Newell-Litwa et al. 2015).  
 Recently, the Notch signaling pathway has emerged as an important regulator of 
endothelial AJs particularly during exposure to laminar shear stress.  For instance, in 
Mack et al. (2017) as well as in Polacheck et al. (2017), loss of Notch1 expression in 
vascular endothelial cells led to the disorganization/loss of VE-cadherin AJs.  Though in 
a slightly different context to the aforementioned two references, in a study by Bentley et 
al. (2014), the authors demonstrated that treatment of sprouting endothelial cells with a 
well-known inhibitor of Notch signaling led to a significant shift towards more 
active/disorganized VE-cadherin junction morphology.  Classically, the Notch pathway 
has been studied in the context of development and tissue morphogenesis, and extensive 
research has demonstrated its important role in dictating cell-cell communication through 
direct juxtaposing (Kopan 2012).  As such, Notch has been implicated in mediating cell 
aggregation and in a variety of contexts, has also been associated with cytoskeletal 
dynamics through Rac1 (Polacheck et al. 2017, Zhou et al. 2013). 
 Given the importance of cellular tension and Notch signaling in regulating 




signaling directly affects the ability of endothelial cell to generate substrate tractions.  
Based on previous literature, we hypothesize that inhibition of Notch receptor activity 
will lead to a reduction in forces across cell-cell contacts through disruption of AJs and 
that this decline will be translated into reduced cell-matrix forces, since the magnitude of 
cell-cell and cell-matrix forces have been intimately linked (Maruthamuthu et al. 2011).  
To test this hypothesis, we utilized traditional 2D TFM techniques and investigated the 
impact of a Notch pathway inhibitor on cell-substrate traction forces.  Though we 
determined that treatment with this Notch inhibitor led to a significant reduction in 
traction stresses, we did not observe noteworthy changes to cell AJ formation or the actin 
cytoskeleton.  However, analysis into the tethering of these endothelial cells to the ECM 
through examination of their ability to establish focal adhesions revealed marked 
reductions in the adhesive area of Notch inhibited cells.  Based on these findings, we 
speculate that Notch signaling at baseline levels may directly influence cell-matrix 
adhesive properties, thereby precluding Notch-inhibited cells from being capable of 
responding to subsequent exposure to barrier modulators.  Future work to further dissect 
these hypotheses will be necessary and are discussed later in this chapter as well as in 
Chapter 5.1. 
 
Materials and Methods 
Cell culture. Human dermal microvascular endothelial cells (hMVEC-Ds, Lonza) 
were cultured in EGM2-MV (Lonza) and used at passages 2-8. hMVEC-Ds were 




mycoplasma testing was provided by Lonza. 
Fabrication of micropatterned polyacrylamide hydrogel substrates for TFM. 
hMVEC-Ds were cultured on ~140um X 140um square collagen I micropatterned 
polyacrylamide substrates for traction force measurements. Patterned substrates were 
prepared through standard techniques (Ribeiro et al. 2015). Briefly, patterned glass 
coverslips were generated through microcontact printing using an elastomeric PDMS 
stamp. The PDMS stamp was generated using standard photolithography techniques as 
previously outlined in (Ruiz & Chen). The stamp was incubated at room temperature for 
1 hour with a 100ug/mL solution of collagen (rat tail type I, Corning) diluted in 0.02% 
acetic acid before being washed with deionized water. After light air drying, the collagen-
inked stamp was brought in contact with an isopropanol-cleaned coverslip (18mm round, 
No.1) for at least 30 seconds before being removed and used for gel polymerization. 
Glass-bottom dishes (35mm, MatTek Corp.) to support polyacrylamide binding 
were plasma-activated for 60 seconds and treated with 2% v/v 3-(trimethoxysilyl)propyl 
methacrylate (Sigma) and 1% v/v glacial acetic acid (Sigma) in 190 proof ethanol for 10 
minutes at room temperature. Dishes were washed three times with 190 proof ethyl 
alcohol before being air dried and incubated at 60°C for at least 2 hours.  
Polyacrylamide gels with 4kPa stiffness were fabricated. Briefly, a solution of 
40% acrylamide (Bio-Rad Laboratories), 2% bis-acrylamide (Bio-Rad Laboratories), 
1.75% v/v 0.5um fluorescent beads (Dragon Green, Bangs Lab) and 1X PBS was 
polymerized through the addition of tetramethylethylene diamine (Fisher BioReagents) 




functionalized glass-bottom dish and sandwiched on top with the collagen micropatterned 
coverslip. The solution was left to polymerize at room temperature for 45 minutes before 
hydrating with 1X PBS for at least 30 minutes. Subsequently, the top coverslip was 
removed with tweezers and the gel substrate was UV sterilized for 15 minutes before 
being stored in 1X PBS. Gel substrates were utilized within 7 days after fabrication.  
Bead displacement imaging and TFM analysis. For TFM measurements, 
polyacrylamide substrates were seeded with ~50,000 hMVEC-Ds for 1 hour before non-
adhered cells were removed by washing 1X with growth media. Cells seeded onto 
substrates were maintained in growth media and at normal culture conditions for 18-36 
hours. Prior to TFM measurements, cells were labeled with a membrane dye (Deep Red 
Cell Mask, Invitrogen) diluted in growth media (1:4000) for 3 minutes before being 
washed once and left to equilibrate at normal growth conditions for at least 1 hour.  
Traction forces exerted by multicellular patterns of hMVEC-Ds were computed 
by imaging the fiduciary fluorescent beads embedded in the polyacrylamide and 
measuring their displacement using previously described methods (Tseng et al., 2012) 
(Software available at https://sites.google.com/site/qingzongtseng/tfm). Briefly, images 
of surface-level beads within and around the patterned multicellular square islands were 
captured at least 20 minutes after transfer of substrates to the microscope (Yokogawa 
CSU-21/Zeiss Axiovert 200M inverted spinning disk microscope with a Zeiss LD C-
Apochromat 20X, 0.8N.A. objective and an Evolve EMCCD camera) environmental 
chamber (37°C, 5% CO2). These images were used to determine the “pre-treatment” 




images were obtained, N-[N-(3,5-Difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl 
ester (DAPT, 40uM final, Sigma), Blebbistatin (50uM final, Cayman Chemical), S1P 
(500nM final, Cayman Chemical) and the vehicle controls were diluted in growth media 
was added to the samples. After 40 minutes of exposure to drug, “post-treatment” 
stressed images were captured. Finally, “relaxed” images illustrating the zero-stress state 
locations of the beads were obtained by lysing cells with 0.01% v/v Triton-X and 
allowing the substrate to equilibrate for at least 60 seconds.  
Bead displacement vectors were determined using the Particle Image Velocimetry 
ImageJ plug-in (Tseng et al., 2012) with a final window size of ~22.7um X 22.7um. 
Based on these bead displacement vectors, traction stress fields were generated using the 
Fourier Transform Traction Cytometry ImageJ plug-in (Tseng et al. 2012). A 
regularization parameter of 5e-9 was set for all traction stress reconstructions. The total 
“pre-treatment” and “post-treatment” traction stresses were calculated as the sum of 
traction stress magnitudes for the entire image field of view.  
Immunofluorescence staining and imaging. For morphological analysis of 
adherens junctions and cytoskeletal components, cells cultured in complete medium on 
patterned polyacrylamide substrates were treated with inhibitor for 90 minutes, then 
immediately fixed with 2% paraformaldehyde in EBM for 10 minutes at room 
temperature and rinsed three times in 1X PBS before permeabilization with 0.2% Triton-
X 100 for 10 minutes at room temperature. Cells were blocked with 2% w/v bovine 
serum albumin (BSA) in 1X PBS for 1 hour at room temperature or overnight at 4°C. 




rinsed three times with 1X PBS in between.  
For immunofluorescence imaging, images were acquired using a Yokogawa CSU-
21/Zeiss Axiovert 200M inverted spinning disk microscope with a Zeiss LD C-
Apochromat 1.1 N.A. water-immersion objective and an Evolve EMCCD camera 
(Photometrics). Fluorescence images were adjusted for brightness and contrast using 
ImageJ.  
Quantification of VE-cadherin, F-actin, and focal adhesions.  VE-cadherin, F-
actin, and focal adhesions were stained for using the following reagents:  Primary mouse 
VE-cadherin antibody (1:300, Alexa Fluor 647, BD), Primary mouse Paxillin antibody 
(1:300, BD), Phalloidin (1:500, Rhodamine, Thermo).  To quantify VE-cadherin, F-actin 
content, and focal adhesions, greyscale confocal images were converted into Z-stacks 
before background subtraction was applied using a 10-pixel rolling ball radius.  The 
resulting images were thresholded through Otsu’s method, and the “Analyze Particles” 
function was used to quantify the VE-cadherin-positive and F-actin-positive area.  For 
focal adhesions, the total number and total area of particles ranging in size from 20-200 
pixels was quantified. 
 
Results 
Micropatterning of cell-adhesive islands enables the measurement of multicellular 
traction stresses 
In order to understand how Notch signaling directly impacts the ability for 




classic techniques in 2D traction force microscopy (TFM).   Briefly, this approach 
consists of generating elastic polyacrylamide hydrogels that are embedded with fiduciary 
fluorescence beads and can be seeded with cells.  Using high-resolution microscopy, the 
displacement of these beads generated by the contractility of adherent cells can be 
tracked and utilized to calculate cell-produced traction forces (Polacheck & Chen, 2016).  
In our system, we chose to generate polyacrylamide substrates with defined adhesive 
patterns using techniques in microcontact printing (Figure 2.1).  This approach was taken 
to allow for the ability to monitor changes to entire multicellular monolayers within one 





To validate this platform and our method for quantifying traction stresses, we 
chose to assay the effect of two known modulators of cell-generated traction forces.  
Blebbistatin is an inhibitor of non-muscle myosin II that prevents the ability for cells to 
generate contractile forces through the actin cytoskeleton (Kovacs et al. 2004).  In 
various cell types, blebbistatin has been shown to reduce measured traction stresses 
(Beningo et al. 2007, Kraning-Rush et al. 2012).  To test the effect of blebbistatin on our 
system, we measured the initial traction stresses generated by individual patterned islands 
before treatment and compared these values to those of the same patterns after 45 minutes 
of exposure to blebbistatin.  This strategy was chosen in order to eliminate the effect of 
Figure 2.1 Confined monolayers of endothelial cells are generated by patterning 
square islands onto polyacrylamide gels using standard microcontact printing 
techniques.  (A) Patterns of collagen I squares are generated by microcontact printing 
using elastomeric PDMS stamps.  The polyacrylamide gels, containing fluorescent 
microbeads, are polymerized onto silanized glass coverslips.  (B) Square collagen I 
patterns can be visualized using fluorescently labeled collagen. Squares are ~140µm x 
140µm in size and are separated by ~100µm.  Scale bar is 150µm.  (C) hMVECs seeded 
onto the patterned substrates form small monolayers in the shape of the patterned 




traction stress variability among individual patterns even within the same sample.  
Indeed, we found that while the vehicle control treated patterns showed relatively small 
changes in total traction stresses generated during this period, blebbistatin treated patterns 
demonstrated about a 25% reduction in generated stresses (Figure 2.2A, B).  On the other 
hand, to demonstrate that this platform can also reflect increases in generated traction 
stresses, we treated patterned cells with S1P, a known activator of Rac1 and inducer of 
barrier function through strengthening of endothelial cell-cell junctions (Xiong and Hla, 
2014).  As was expected based on previously published data (Yang et al. 2011), S1P 
induced a nearly 50% increase in the measured traction stresses after 45 minutes of 
treatment (Figure 2.3A, B).  Together, these data confirmed that this assay platform can 
be utilized to measure substrate traction stresses generated by patterned monolayers of 
endothelial cells and can reflect both increases and decreases of measured traction 






Figure 2.2: Blebbistatin treatment of patterned monolayers causes an expected 
decrease in measured traction stresses.  (A) Representative traction stress maps of 
vehicle-treated and blebbistatin-treated patterned monolayers.  Maps in the left column 
represent traction fields of cells immediately before treatment, and maps in the right 
column represent traction fields approximately 45 minutes after treatment.   Red outline 
indicates the perimeter of the patterns.  Scale bars are 50µm.  (B) Quantification of the 
change in total traction stresses. N = 2 samples per condition. Bars represent mean ± SD. 
** represents p < 0.01 as determined by a t test. 
Figure 2.3: S1P treatment of patterned monolayers causes an expected increase in 
measured traction stresses. (A) Representative traction stress maps of vehicle-treated 
and S1P-treated patterned monolayers.  Maps in the left column represent traction fields 
of cells immediately before treatment, and maps in the right column represent traction 
fields approximately 45 minutes after treatment.   Red outline indicates the perimeter of 
the patterns.  Scale bars are 50µm.  (B) Quantification of the change in total traction 
stresses. N = 2 samples per condition. Bars represent mean ± SD. ** represents p < 0.01 




Inhibition of Notch signaling leads to a decrease in cell-matrix forces generated by 
multicellular monolayers 
 Having validated our assay platform and quantification method of traction 
stresses, we sought to probe the impact of Notch signaling inhibition on monolayer-
derived traction stresses.  To induce inhibition, we chose to use the small molecule 
inhibitor of γ-secretase, DAPT, which has been extensively utilized in both in vitro and in 
vivo systems to inhibit Notch activity primarily in the context of angiogenesis (Suchting 
et al. 2007, Zheng et al. 2017, Jakobsson et al. 2010).  Upon ~45 minutes of treatment 
with DAPT, we observed a ~15% reduction in total traction stresses generated by each 
patterned endothelial monolayer (Figure 2.4A, B).  We elected to limit DAPT exposure to 
relatively short periods of time in order to more directly probe how acute inhibition of 
Notch would impact cell contractility, as effects observed after long-term treatments 
(typically 12-24 hours) could be confounded by additional change to downstream gene 
expression changes that are under the control of Notch signaling.  Given the level of 
variability in the magnitude of total traction stresses observed between each pattern as 
well as the cell density of each pattern (data not shown), we sought to evaluate whether 
the change in traction stresses due to DAPT treatment was dependent on cell density.  
Plotting the change in traction stresses observed after treatment against the number of cell 
nuclei within each pattern, we found no significant correlation as reported by the Pearson 
correlation coefficients (Figure 2.5).  This observation is in line with findings from other 
works suggesting that traction stresses are positively correlated with adhesive area 





Figure 2.4: DAPT treatment of patterned monolayers causes a decrease in 
measured traction stresses. (A) Representative traction stress maps of vehicle-treated 
and DAPT-treated patterned monolayers.  Maps in the left column represent traction 
fields of cells immediately before treatment, and maps in the right column represent 
traction fields approximately 45 minutes after treatment.   Red outline indicates the 
perimeter of the patterns.  Scale bars are 50µm.  (B) Quantification of the change in total 
traction stresses. N ≥ 4 samples per condition. Bars represent mean ± SD. **** 
represents p < 0.0001 as determined by a t test. 
Figure 2.5: Change in total traction stresses with DAPT treatment is not dependent 
on the number of cells seeded in the pattern.  For each endothelial pattern measured, 
the change in total traction stresses after treatment is plotted against the number of nuclei 
found in within that pattern after treatment. The Pearson Correlation Coefficients for 




DAPT treatment does not lead to significant changes in baseline VE-cadherin junction 
assembly or F-actin content 
 In previous studies, it has been established that the magnitude of substrate forces 
is positively correlated with cell-cell forces, and increases in cell-cell forces are in turn 
linked to enhancement of AJs (Maruthamuthu et al. 2011, Liu et al. 2010).  Additionally, 
Krishnan et al. (2011) have demonstrated that treatment of endothelial monolayers with a 
blocking antibody against VE-cadherin leads to a reduction in cell contractility.  Based on 
these observed decreases in ECM tractions and recent reports suggesting that Notch 
signaling is intimately linked to AJ assembly and reinforcement (Mack et al. 2017, 
Polacheck et al. 2017), we hypothesized that the reduction in total traction stresses caused 
by DAPT treatment might be linked to a reduction in cell-cell forces as a result of 
weakening AJs.  As such, we evaluated the impact of DAPT treatment on VE-cadherin 
junctional area and F-actin content within our system.  Unlike these previous findings, 
however, we did not observe any marked changes in junctional area or F-actin content 






DAPT treatment leads to changes in paxillin-based focal adhesions 
These observations led us to investigate alternative mechanisms through which 
cell-matrix forces may be directly modulated in response to DAPT treatment.  
Specifically, we looked into focal adhesions through immunofluorescence staining of 
paxillin.  Paxillin is a protein that interacts with the intracellular domain of engaged 
integrin transmembrane receptors and works in concert with other focal adhesion proteins 
to link the ECM and cellular cytoskeleton (Deakin & Turner 2008).  From our 
preliminary analysis, we observed that treatment with DAPT led to a decrease in the total 
number and total area of paxillin-based focal adhesions (Figure 2.7).  Intriguingly, we 
also qualitatively observed that in the vehicle-treated group, these focal adhesions tended 
Figure 2.6: Notch inhibition does not significantly alter VE-cadherin junctions or F-
actin content. (A) Representative fluorescence images of vehicle-treated and DAPT-
treated cells stained for VE-cadherin (green) and DAPI (blue). Scale bar is 50µm.  (B) 
Quantification of total VE-cadherin junctional area per field of view.  (C) Representative 
fluorescence images of vehicle-treated and DAPT-treated cells stained for F-actin (red) 
and DAPI (blue).  (D) Quantification of total F-actin content per field of view.   Scale bar 
is 50µm.  N = 1 sample, 8 or 13 randomly selected fields of view. Bars represent mean ± 




localized to areas of the cell periphery.   
 
Discussion 
 In this chapter, we began to explore the role that the Notch signaling pathway 
plays in mediating cell-matrix interactions.  Using traditional 2D TFM techniques, we 
evaluated the impact of Notch signaling inhibition on traction stresses generated by 
multicellular aggregates of endothelial cells and observed that inhibition via treatment 
with a small molecule inhibitor led to a nearly 15% decrease in total measured traction 
stresses.  Preliminary results via immunofluorescence staining for paxillin indicate that 
this reduction in tractions was accompanied by decreases in the number and total area of 
Figure 2.7: DAPT treatment leads to a decrease in paxillin-based focal adhesions.  
(A) Representative fluorescence images of vehicle-treated and DAPT-treated cells 
stained for paxillin (green) and DAPI (blue). Scale bar is 50µm.  (B) Quantification of 
focal adhesion number and total focal adhesion area per field of view.  N = 1 sample, 13 
randomly selected fields of view. Bars represent mean ± SD. **** represents p < 0.0001 





focal adhesions.   Intriguingly, in other cell types, Notch signaling has been linked to 
substrate adhesive properties.  For instance, in breast cancer cells, loss of Notch1 has 
been associated with reduced substrate adhesiveness and diminished activation of focal 
adhesion proteins such as focal adhesion kinase (FAK) (Li et al. 2014, Wang et al. 2011).  
Similarly, treatment of rhabdomyosarcoma cells with a γ-secretase inhibitor led to a 
reduction in cell adhesion to collagen substrates as well as a decrease in expression of 
integrin α9 (Masia et al. 2012).  While these studies have been conducted using 
malignant cell lines, they indicate a potential link between the Notch pathway and cell 
adhesion and serve to support our working hypothesis that Notch signaling may directly 
affect endothelial cell adhesion within our system.  However, future studies to validate 
these findings are required, and subsequent experiments to directly probe the impact of 
DAPT on integrin expression or activation of focal adhesion proteins through western 
blot analysis for example will help to corroborate or invalidate this hypothesis. 
 Interestingly, through our evaluation of focal adhesions in our vehicle-treated and 
DAPT-treated endothelial cells, we qualitatively observed spatial localization of paxillin 
puncta towards the cell periphery.  In previously published works, redistribution of 
paxillin to peripheral areas of endothelial cells has been reported after treatment with 
barrier enhancing agents such as oxidized phospholipids as well as S1P (Birukova et al. 
2008, Sun et al. 2009).  It has been proposed that traditional focal adhesion proteins like 
paxillin and vinculin present at or near cell-cell junctions due to enhanced integrin-
mediated cell-matrix tethering, which may act to reduce the extent of cell-cell retraction 




localization towards the cell periphery in the control setting may indicate that these cells 
are primed to resist subsequent exposure to permeability enhancing reagents and would 
be capable of recovering barrier function relatively quickly after insult.  On the other 
hand, loss of paxillin focal adhesions in the DAPT treated condition may indicate that 
these cells would not be able to withstand or recover from exposure to permeability 
inducting factors.   
 Rather than through direct impact on integrin-mediated matrix adhesion, it is 
possible that Notch inhibition reduces cellular traction stresses due to its effect on other 
mediators of cell tension.  In Polacheck et al. (2017), the authors demonstrated that 
treatment with DAPT or loss of Notch1 expression in endothelial cells leads to a 
significant reduction in Rac1 activity.  In other contexts, activation of Rac1 is linked to 
the formation of small focal adhesions/focal complexes and the recruitment of non-
muscle myosin to focal adhesion sites, which in turn regulates changes in traction stress 
generation (Nobes & Hall 1995, Pasapera et al. 2015).  Incidentally, Rac1 has also been 
shown to be critical for mediating paxillin redistribution to the cell periphery upon 
stimulation with barrier-enhancing oxidized phospholipids.  In endothelial cells 
expressing constitutively active Rac1, paxillin is readily found at junctional regions, 
whereas cells with dominant negative Rac1 do not respond in this manner to stimulation 
(Birukova et al. 2008).  These aforementioned published findings might suggest that 
DAPT could be directly impacting Rac activity at cell-matrix interactions within our 
system, thereby causing a reduction in focal adhesions as well as traction stresses.   




endothelial cells has been shown to regulate adherens junction integrity (Wójciak-
Stothard et al. 2001).  As such, given the ability for Rac1 to modulate both cell-cell and 
cell-matrix interactions, we cannot completely exclude the possibility that the reduction 
in traction stresses we observe in our system upon Notch inhibition is linked to a direct 
impact on both of these spatially localized functions of Rac1.  Within our system, 
however, we did not observe any drastic changes to cell-cell adhesions based on 
immunofluorescence staining for VE-cadherin.  We hypothesize that this is due to the 
fact that we are studying these endothelial cells under static, baseline conditions.  In 
several previously published works, it has been demonstrated that exposure to shear 
stress induces Rac1 activation and strengthening of cell-cell junctions and endothelial 
barrier function (Collins & Tzima 2014).  Thus, while there may be some baseline Rac 
activity at cell-cell junctions in our system, we postulate that the effects we observe upon 




CHAPTER 3: THE ROLE OF MYOSIN-MEDIATED CELL CONTRACTILITY 
IN SPROUTING ANGIOGENESIS 
3.1 Introduction 
Collective migration is a process in which cohorts of cells move in a coordinated 
fashion such that cell-cell contacts are maintained.  It is a highly regulated process that is 
critical in a variety of pathological and developmental morphogenic events such as tumor 
cell invasion and sprouting angiogenesis (Friedl & Gilmour 2009; Scarpa & Mayor 
2016).  This cooperative movement of cells is of particular importance during sprouting 
morphogenesis given that the endothelial cells which make up new vessels must form 
patent structures capable of supporting blood flow.  The three-dimensional (3D), 
multicellular structures that form during sprouting are classically composed of leader 
endothelial cells, coined tip cells, which proteolytically degrade the surrounding 
extracellular matrix to migrate towards sources of angiogenic factors.  As they advance, 
tip cells retain physical cell-cell adhesions with a trailing cohort of stalk cells that form 
the lumenized trunk of the sprout (Adams & Alitalo 2007; Carmeliet et al.  2009).  
Although questions surrounding the molecular drivers of sprouting and how tip and stalk 
cell identities are regulated by receptor signaling, have been extensively researched, via 
the VEGFR2 and Notch1-DLL4 pathways for example, much less investigation into how 
cellular mechanics and force regulation influence sprouting morphogenesis has been 
accomplished (Gerhardt et al.  2003; Hellstrom et al.  2007; Benedito et al.  2009). 
Broadly speaking, many of the signaling pathways driving essential cytoskeletal 




a bipolar motor protein that crosslinks actin filaments, strengthens cell-substrate 
adhesions, and directly produces actomyosin-based contractile forces (Vicente-
Manzanares et al. 2009).  Given the critical importance NMII specifically holds in 
regulating many aspects of cell contractility and migration, it is likely to play an essential 
role in sprouting angiogenesis where dynamic, spatially regulated cell-cell adhesions, 
mechanical linkage of cell cytoskeletons, and matrix interactions are involved.  
Nonetheless, its direct role in sprout morphogenesis remains unresolved.  Several groups 
have studied how impairment of cell contractility affects the 3D invasiveness and 
migration directionality of endothelial cells for example, but the majority of these studies 
have been limited to perturbing upstream regulators of NMII like RhoA and ROCK 
rather than NMII directly (Kroll et al. 2009; Breyer et al. 2012).  In these cases, 
concurrent changes in activity of other downstream effectors of RhoA and ROCK may 
limit the ability to attribute any changes in sprouting solely to alterations in NMII 
activity.  On the other hand, in studies where direct modifications in the expression or 
activity of NMII have been investigated, angiogenic potential has been assayed in two-
dimensional (2D) settings that do not recapitulate the inherent 3D nature of angiogenesis 
(van Nieuw Amerongen et al. 2002; Uchida et al. 2000; Lyle et al. 2012).  Since it is 
known that the behavior of cells grown on planar substrates often varies greatly from 
those cultured within three-dimensional settings, for example by affecting cell shape and 
focal adhesion assembly (Baker & Chen 2012), it is uncertain whether conclusions drawn 
from 2D studies can be directly applied to 3D processes.  In fact, in epithelial cells, it has 




increased migration speeds on 2D substrates but slowed them in 3D (Shih & Yamada 
2010), supporting the notion that the role of NMII in cell migration and morphogenesis is 
context dependent.  To date, a systematic study underscoring the role of purely NMII-
mediated cell contractility in 3D sprout morphogenesis has yet to be completed.   
In this work, we aim to fulfill this gap in knowledge and answer some basic, 
outstanding questions centered around the function of NMII-mediated cell contractility 
during angiogenesis.  To this end, we first established a general understanding of how 
endothelial cells within multicellular sprouts generate contractile forces through the use 
of a microfluidic, 3D model of angiogenesis.  Using a NMII-specific inhibitor, 
blebbistatin, and CRISPR-Cas9-mediated gene editing, we then specifically perturbed 
NMII-generated contractility in order to establish the functional significance of these 
forces in sprout morphogenesis.  Our findings together reveal a vital role for NMII-
generated contractile forces in maintaining the multicellularity of new sprouts formed 
during angiogenesis.   
 
3.2 Materials and Methods 
Cell culture.  Primary human umbilical vein endothelial cells (Lonza) were 
maintained in endothelial growth media EGM-2 (Lonza) and used at passages 4-8. 
Human HEK-293T cells (Clonetech) were cultured in high-glucose DMEM (Hyclone) 
supplemented with 10% fetal bovine serum (Hyclone), 100 U ml−1 penicillin, 100 µg 
ml−1 streptomycin (Life Technologies) and 2 mM L-glutamine (Life Technologies).  All 




Antibodies and Reagents.  Mouse anti-VE-cadherin antibody (1:100; sc-9989; 
Santa Cruz), Mouse anti-CD31 antibody (1:200; JC70A; Dako), Donkey anti-mouse 
secondary (1:500; Alexa Fluor 568 A10037; Invitrogen), Goat anti-mouse secondary 
(1:500; Alexa Fluor 568 A11031; Invitrogen), Alexa Fluor 488-conjugated phalloidin 
(1:500; A12379; Invitrogen), Rat anti-mouse VE-Cadherin antibody (1:50; clone 11D4.1; 
BD Bioscience), Donkey anti-rat secondary (1:300; Cy3; Jackson Lab), anti-rat IgG 
Alexa Fluor 568 (1:300; Invitrogen), isolectin B4 (Vectorlabs), Rabbit anti-Non-muscle 
myosin heavy chain II-A (1:10,000; 909802l; BioLegend), Rabbit anti-Non-muscle 
myosin heavy chain II-B (1:10,000; ABT1340; Millipore), Goat anti-rabbit secondary 
(1:500, Alexa Fluor 568 A11011; Invitrogen), DAPI (Sigma). 
Lentiviral-mediated CRISPR genome editing.  Stable CRISPR-knockout 
HUVEC cell lines were generated using guide (g)RNAs formulated by the Optimized 
CRISPR Design Tool (F.Zhang). The following gRNA sequences were designed and 
utilized: TCAAGGAGCGTTACTACTCA Exon 1 for MYH9 and 
TGGATTCCATCAGAACGCCATGG Exon 1 for MYH10.  Individual gRNA-
containing plentiCRISPRv2 plasmids were co-transfected with pVSVG, pRSV-REV, and 
pMDLg/pRRE packaging plasmids into HEK-293T cells using calcium phosphate 
transfection. After 48 hours, viral supernatants were collected, concentrated using PEG-
IT viral precipitator (SBI), and resuspended in PBS. HUVECs were transduced in growth 
medium overnight, and medium was replaced the following morning. At 48 hours after 
infection, cells were replated and selected with 2 µg ml−1 puromycin for 3–4 days. All 





Microfluidic device fabrication and seeding for blebbistatin experiments.  For 
blebbistatin treatment experiments, microfluidic devices were fabricated using soft 
lithography techniques as previously described (Nguyen et al. 2013).  For device seeding, 
cells were trypsinized, reconstituted at 106 cells ml-1, and seeded into one of the two 
hollow channels.  The devices were inverted to allow cells to adhere to the top surface of 
the channel for 3 min, and then flipped upright to allow cells to adhere to the bottom 
surface of the channel for another 3 min.  Unattached cells in the channel were then 
thoroughly flushed out with phosphate-buffered saline (PBS).  EGM-2 was immediately 
added thereafter and the devices were placed on a platform rocker (BenchRocker, 
BR2000) in a humidified incubator. Cells were cultured in channels for 1 day before 
angiogenic factors (MVPS cocktail), defined in Nguyen et al. 2013, were introduced. 
Blebbistatin treatment of in vitro sprouts in device. For 5-day blebbistatin 
treatment, cells were simultaneously treated with 30µM blebbistatin (Tocris) and MVPS 
gradient. Blebbistatin treatment was applied to both the cell cannel and MVPS source 
channel such that no gradient of inhibitor was established. Blebbistatin-containing 
cocktail and cell-media were refreshed daily. For 24-hr blebbistatin treatment of 
extending sprouts, cells were cultured in the device under MVPS gradient for 3 days 
before blebbistatin treatment. During this period, media in the cell channel and cocktail in 
the source channel were refreshed daily. Following 3 days of sprouting, blebbistatin or 
vehicle control was added to cell media and MVPS cocktail and used to refresh the 




DMSO (added at amount used for 50 µM blebbistatin treatment). Y-27632 (25µM, 
Tocris) experiments were treated in the same manner.  At the end of all sprouting 
experiments, devices were fixed in warm 3% paraformaldehyde for 25 min at 37°C, 
subsequently rinsed three times with PBS before permeabilization with 0.1% Triton-X for 
20 min. For VE-cadherin staining, devices were blocked with 3% BSA in PBS overnight, 
then treated primary VE-cadherin antibody (1:100) in 3% BSA in PBS overnight, rinsed 
for 6 hours, and incubated with Alexa Fluor-conjugated secondary antibody (1:500), 
Alexa Fluor-conjugated Phalloidin (1:100), and DAPI (1:500, Sigma). 
Image Acquisition and Processing.  All brightfield images of sprouts were 
acquired with a Nikon TE200 epifluorescence microscope (Nikon Instruments, Inc.) 
using a 10x objective. All confocal microscopy for immunofluorescence samples was 
completed with a Yokogawa CSU-21/Zeiss Axiovert 200M inverted spinning disk 
microscope equipped with an Evolve EMCCD camera (Photometrics). ImageJ (NIH) was 
used to merge channels, perform Z-projection for all confocal stacks, and generate 
longitudinal and transverse cross-sections. Custom MATLAB scripts and ImageJ were 
used to stitch images together. 
Quantification of blebbistatin-induced cell-cell breakages.  For each device, 
40X confocal 3D image stacks were collected at three locations equidistance from each 
other along the channel.  Image collections were centered on the midpoint of the channel 
in the z, or vertical, direction. Individual image stacks contained 100 slices, taken at 2µm 
increments in the z direction.  Quantification was completed by scrolling through each 




Numerical data was collected on a) number of tip cells, b) number of detached tip cells, 
c) number of stalk cells, d) number of detached stalk cells.  Tip cells were defined 
morphologically as cells in the leading half of the cellular invasion distance (defined 
from the front of leading cells back to the near edge of the main cell channel), and the 
presence of multiple, long actin-rich protrusions directed toward the gradient source.  All 
other cells were assigned as stalk cells, which were generally located in the back half of 
the invasion and lacked actin-rich protrusions. 
Mouse Retina Studies.  Mice were housed in accordance with the Institutional 
Animal Care and Use Committee at Boston University and the National Institutes of 
Health guidelines.  C57Black/6 mice from Taconic were used for breeding purposes.  
Pups at postnatal day 5 (P5) were injected intraperitoneally with either 5µl of Vehicle 
(DMSO) or Blebbistatin (50mM), diluted in OptiMEM for a total of 50µL in injection 
volume.  Six hours after injection, pups were euthanized, and retinas dissected after 
fixation in 4% paraformaldehyde.  Fixed retinas were then processed for 1h in 3% BSA 
and 0.5% Triton X100.  Retinas were whole mounted, and images were acquired with 
40X, 1.1 N.A. water-immersion objective. 
Microfluidic device fabrication and seeding for NMII CRISPR experiments.  
Polydimethylsiloxane (PDMS, Sylgard 184, Dow-Corning) was mixed at a ratio of 10:1 
(base:curing agent) and cured overnight at 60 °C around stereolithography-printed molds 
(ProtoLabs) designed to maintain key features and dimensions of the microfluidic device 
from Nguyen et al. (2013).  This alternative method of device fabrication was employed 




the master mold, trimmed, surface-activated by plasma treatment for 30 seconds, and 
bonded to glass coverslips.  PDMS devices were surface-functionalized using (SILANE) 
for 3 hours and maintained in an empty vacuum chamber overnight as an alternative 
method to the one described previously in Nguyen et al. (2013).  All other collagen 
formation and cell seeding steps were similar to that of the blebbistatin experiments 
detailed above.  For devices used in bead displacement studies, two types of carboxylated 
polystyrene beads (0.19µm Dragon Green (1:250) and 0.22µm Flash Red (1:400), Bangs 
Labs) were added to the collagen solution immediately prior to polymerization.  Cells 
were cultured in channels for 1 day before angiogenic factors were introduced.   
In these studies, an alternative cocktail of factors was employed: hepatocyte 
growth factor (5.5 ng ml−1, R&D Systems), vascular endothelial growth factor (3 ng ml−1, 
R&D Systems), phorbol myristate acetate (25 ng ml−1, R&D Systems), and sphingosine-
1-phosphate (2 nM, Cayman Chemical).  This cocktail of factors was optimized to 
achieve low sprouting density in this sprouting platform such that bead displacement 
measurements from singular sprouts could be measured.  For consistency, this cocktail 
was also used for morphogenesis studies using the NMII CRISPR cells.  
For these studies, devices were fixed 3 days after the addition of the angiogenic 
cocktail with 4% paraformaldehyde in endothelial basal media (EBM) at room 
temperature for 30 minutes. Devices were rinsed three times with PBS and permeabilized 
with 0.2% Triton-X100 in PBS for 15 minutes. Devices were blocked overnight with 2% 
BSA in PBS, incubated with mouse anti-human CD31 antibody (1:200, Dako) in PBS 




(1:500) and DAPI (1:500).   
Quantification of sprout length and cell-cell breakages of NMIIKO sprouts.  
For each device, confocal Z-stack images of the entire cell channel were acquired with a 
10X air objective. These fluorescence images were adjusted for brightness and contrast 
using ImageJ.  Quantification of total cells invaded out of the main endothelial channel 
were determined through counting the number of nuclei within the matrix.  Measurement 
of sprout length was determined by quantifying the perpendicular distance between the 
leading tip of an intact sprout to the base of that sprout.  Quantification of the number of 
cell-cell breakages was completed by manually scrolling through greyscale micrographs 
of cells immunostained for CD31.   
Collagen bead displacement measurements and quantification.  Sprouts 
formed between Day 3 and Day 4 after exposure to cocktail were analyzed for these 
experiments.  Prior to imaging, cells were labeled with Deep Red Cell Mask (1:2000, 
Invitrogen) for 8 minutes prior to setting the device on the confocal microscope stage 
equipped with an environmental chamber to maintain 37°C temperature and 5% CO2 
levels.  Devices were allowed to equilibrate on the stage for 10-20 minutes prior to 
imaging.  Intact, multicellular sprouts that were sufficiently isolated from surrounding 
cells were identified, and “stressed” state Z-stack images of the sprout and beads were 
captured with a 0.8µm step size.  Immediately after, devices were treated with 0.1% 
Triton-X in PBS for 30 minutes to allow for cell lysis and relaxation of the matrix.  
Finally, “zero-stress” images of the same region of interest was captured.  Bead 




Briefly, sprout surface meshes were generated through manual border identification in 
Amira (Visage Imaging).  The 2D surface mesh of the sprout was generated from the 
segmented image and imported into Hypermesh (Altair) as a stereolithography file.  The 
final surface meshes were imported into Abaqus (Dassault Systèmes) for finite element 
analysis.  Bead displacements were calculated through a custom MATLAB code. 
Renderings of bead displacements and the corresponding sprout surface meshes were 
generated using Tecplot 360 (Tecplot Inc.).   
2D dextran gel fabrication.  RGD-modified dextran hydrogels were employed to 
measure 2D traction stresses generated by NMIIKO cells.  The dextran gel was prepared 
as previously described in Trappmann et al. (2017), mixed with fluorescent fiduciary 
beads (0.19µm Dragon Green (1:400), Bangs Labs), and cast between a glass bottom 35 
mm dish (MatTek) and a SurfaSil (Sigma) treated glass coverslip.  After gel 
polymerization at room temperature for 45 minutes, PBS was added to the gel and the top 
coverslip was removed with tweezers. The gel was washed twice with PBS and seeded 
with endothelial cells at 30,000 cells/substrate for 1 hour.  Afterwards, any remaining 
unattached cells were washed with EGM-2 and substrates were returned to the incubator 
overnight.   
Bead displacement imaging and TFM analysis. Prior to TFM measurements, 
cells were labeled with a membrane dye (Deep Red Cell Mask, Invitrogen) diluted in 
growth media (1:4000) for 3 minutes before being washed once and left to equilibrate at 




Traction forces exerted by cells were computed by imaging the fiduciary 
fluorescent beads embedded in the dextran gel and measuring their displacement using 
previously described methods (Tseng et al., 2012) (Software available at 
https://sites.google.com/site/qingzongtseng/tfm). Briefly, images of surface-level beads 
within and around the patterned multicellular square islands were captured at least 20 
minutes after transfer of substrates to the microscope (Yokogawa CSU-21/Zeiss Axiovert 
200M inverted spinning disk microscope with a Zeiss LD C-Apochromat 25X, 0.8N.A. 
objective and an Evolve EMCCD camera) environmental chamber (37°C, 5% CO2).  
Once all “stressed” images were obtained, “relaxed” images illustrating the zero-stress 
state locations of the beads were obtained by lysing cells with 0.1% v/v Triton-X and 
allowing the substrate to equilibrate for at least 60 seconds.  
Bead displacement vectors were determined using the Particle Image Velocimetry 
ImageJ plug-in (Tseng et al., 2012) with a final window size of ~18.2um X 18.2um. 
Based on these bead displacement vectors, traction stress fields were generated using the 
Fourier Transform Traction Cytometry ImageJ plug-in (Tseng et al., 2012). A 
regularization parameter of 4.0e-9 was set for all traction stress reconstructions, and a 
Young’s Modulus of 2500Pa was used based on atomic force microscopy 
characterization from Trappmann et al. 2017. The root mean square (RMS) traction 
stresses were calculated from the vectors which were greater in magnitude than that of 






Angiogenic sprouts produce spatially-organized matrix deformations 
To investigate the importance of cell contractility in sprouting angiogenesis, we 
first sought to determine if and where forces are generated in multicellular sprout 
structures in the 3D biomimetic model of angiogenesis previously developed in our lab 
(Nguyen et al. 2013).  Briefly, this microfluidic device consists of two hollow cylindrical 
channels embedded in a central collagen hydrogel compartment.  In one channel, 
endothelial cells are seeded and form a uniform monolayer and in the opposing channel, a 
cocktail of angiogenic factors is supplied.  To enable measurement of cell-generated 
matrix deformations, we adapted this platform such that fiduciary fluorescent beads were 
embedded into the collagen matrix.  Using methods of 3D traction force microscopy, we 
measured the magnitude of bead displacements generated by the tip and stalk cells of 
sprouts that formed three to four days after the initiation of cocktail exposure (Legant et 
al. 2010).  In these sprouts, we observed significant deformations generated at the leading 
front of the sprout (Figure 3.1A).  The magnitude of these displacements are within the 
same order of magnitude as those generated by other cell types in a similar collagen 
matrix (Koch et al. 2012, Thievessen et al. 2015).  Along the stalk of the sprout, the 
majority of the measured displacements were generally lower in magnitude, suggesting 
that the leading cell is likely the predominant force generating unit within a sprout.  
Closer examination of the displacements at the leading front revealed that these 
displacements pointed inward towards the sprout, indicating that forces generated by the 
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Inhibition of myosin-mediated contractility alters multicellularity of sprout 
morphogenesis in vitro and in vivo 
Given this understanding of the forces generated by angiogenic sprouts as well as 
the global importance of actomyosin contractility in producing cellular traction forces, we 
sought to investigate the morphogenic significance of cell-generated forces during 
sprouting.  To this end, a gradient of angiogenic factors was applied within our in vitro 
sprouting model in the presence of blebbistatin, a small-molecule inhibitor of NMII.  We 
exposed the endothelialized channel to blebbistatin and angiogenic factors 
simultaneously in order to study how inhibition of NMII may affect sprout 
morphogenesis from the onset.  After five days of exposure, sprouts were fixed and 
stained for analysis (Figure 3.1B).  While inhibition of cell contractility had no 
appreciable effect on the cellular density and speed of invasion from the parent vessel 
through the collagen matrix (Figure 3.1C, D), blebbistatin treatment dramatically altered 
the collective nature of migration.  Specifically, the invasive phenotype under inhibited 
contractility showed an increase in frequency of cell-cell breakages as compared to 
sprouting achieved in the presence of the vehicle control (Figure 3.1E).   
In order to parse out whether this breakdown in multicellularity can specifically 
be attributed to contractility inhibition during sprout elongation as opposed to other 
stages of sprout development such as initiation of invasion, we applied blebbistatin for 24 
hours to pre-formed, intact multicellular sprouts.  Specifically, following three days of 
angiogenic factor stimulation, the devices were exposed to varying concentrations of 




fixed, stained for analysis, and evaluated for sprout morphology through high-
magnification imaging.  While sprouts in the control treatment group formed highly 
multicellular structures with few sporadic detached cells within the invasion region, 
treatment with blebbistatin in a dose-dependent manner resulted in an increasing loss of 
cell-cell contacts between cells (Figure 3.1F).  In this analysis, we categorized the cell-
cell breakages as either tip-stalk or stalk-stalk, depending on whether the breakage 
occurred between a leader cell and its following stalk cell or between two non-leader 
cells, respectively.  At the highest dose of blebbistatin, we observed a significant increase 
in the number of tip-stalk breakages as compared to the control group.  On the contrary, 
this dose of blebbistatin did not induce a significant increase in the incidence of stalk-
stalk breakages (Figure 3.1G).  To corroborate the finding that cell contractility aids in 
maintaining multicellularity, we examined the impact of Y-27632, a selective Rho-
associated kinase (ROCK) inhibitor, on sprouting.  Indeed, ROCK inhibition also led to a 










To establish the relevance of these findings in an in vivo system, we used a mouse 
retina model in which the developmental progression of vascular network formation 
across the neuroepithelium are well-established during the first week of life.  Mouse pups 
at postnatal day 5 (P5) were injected with blebbistatin and sacrificed six hours after 
treatment.  These retinas were subsequently dissected, fixed, and stained for the 
endothelial cells using isolectin B4.  In corroboration with our in vitro findings, a 
significant number of detached endothelial cells appeared at the migrating front of the 
developing vascular network (Figure 3.3A, B).  Together, these in vitro and in vivo 
findings suggest that NMII-generated forces are not necessarily required for enabling 3D 
chemotaxis of endothelial cells toward gradients of angiogenic factors but are required 
for the maintenance of their multicellularity during sprout extension.   
Figure 3.2: Inhibition of ROCK leads to a similar breakdown of sprout 
multicellularity. (A) Representative F-actin (phalloidin, green) and nuclei (DAPI, blue) 
images of sprouts at Day 4 after 48-hour 25µM Y-27632 treatment. Scale bar is 50µm. 
(B) Quantification of detached tip cells (left plot) and stalk cells (right plot) following 
Y-27632 treatment. N=4 devices per condition. Bars represent mean ± SEM. * 





Cell-cell adhesions are disrupted upon contractility inhibition 
Vascular endothelial (VE)-cadherin is the dominant cadherin junctional protein 
within AJs of endothelial cells and has been shown to regulate vascular permeability, 
dynamic cell adhesions, and transcellular signaling (Lampugnani et al.  1992, Mehta & 
Malik 2006).  Cadherins within endothelial AJs have also been shown to link with the 
cell cytoskeleton by the dynamic, phosphorylation-mediated binding of the intracellular 
cadherin domain to the actin cytoskeleton via protein complexes consisting of molecular 
partners like α-catenins and β-catenins (Aberle et al.  1994, Jou et al.  1995).  Given the 
Figure 3.3: Blebbistatin treatment leads to enhancement of single endothelial cells in 
developing mouse retinas. (A) Representative fluorescence images of mouse retinas 
stained for endothelial cells (Isolectin B4, green) and nuclei (DAPI, blue). Scale bars are 
100µm (upper panels) and 50µm (lower panels). (B) Quantification of the number of 
single, detached endothelial cells per imaging field of view. N > 5 retinas per condition. 




importance of VE-cadherin in maintaining cell-cell junctions as well as the molecular 
connection between VE-cadherin and the actin cytoskeleton, we sought to determine 
whether alterations in the quality of cell-cell junctions occur in response to NMII 
inhibition.   
To this end, Day 3 sprouts were treated with blebbistatin for 24 hours and 
subsequently fixed and immunostained for VE-cadherin.  High-magnification confocal 
images of these samples were captured, segmented into regions of tip-stalk and stalk-
stalk adhesions, and characterized as either discontinuous or continuous (Figure 3.4A, B).  
In control conditions, we generally found that most junctions appeared to have a 
continuous morphology, which is characteristic of a more stable phenotype (Figure 3.4C).  
With increasing blebbistatin concentration, tip-stalk adhesions became difficult to 
observe due the increase in cell-cell breakages.  However, quantification of the tip-stalk 
adhesions which survived blebbistatin treatment appeared heavily punctate and 
discontinuous in profile, suggesting that the junctions were unstable (Figure 3.4C).  In 
fact, in the conditions with the strongest NMII inhibition, almost all the observed tip-stalk 
adhesions were classified as discontinuous.  Similarly, stalk-stalk cell adhesions shifted 
to an increasingly unstable adhesion profile in a dose-dependent manner (Figure 3.4D).  
At the highest level of blebbistatin treatment, nearly 50% of the stalk-stalk junctions were 
categorized as discontinuous.  Together, these results demonstrate that broad inhibition of 
NMII activity also causes disorganization of cell-cell junctions, which may in part 





The NMII isoform A is predominantly responsible for maintaining multicellularity during 
sprouting 
In this work thus far, the observations connecting NMII-mediated cell 
contractility and cell-cell adhesiveness during sprouting have been solely been made 
Figure 3.4: Inhibition of myosin-mediated contractility alters the organization of 
cell-cell adhesions. (A) Representative confocal immunofluorescence images of tip-stalk 
(upper panel) and stalk-stalk (lower panel) adhesions from indicated conditions at Day 4, 
after 24-hour blebbistatin treatment. VE-cadherin is shown in white, nuclei are shown in 
blue. Scale bars are 20µm. B) Representative images of cataloged of adhesion types. 
Scale bar is 25µm. (C) Quantification of adhesion profiles of tip-stalk adhesions across 
treatment groups.  (D) Quantification of adhesion profiles of stalk-stalk adhesions across 
treatment groups.  N=3 devices per condition. Bars represent mean ± SEM. * represents p 





based upon broad small-molecule inhibition of NMII.  However, there is a growing body 
of evidence highlighting differential roles of distinct non-muscle myosin II isoforms in 
various cell types and functions (Shih & Yamada 2010; Gutzman et al. 2015; Liu et al. 
2014; Jorrisch et al. 2013).  Motivated by these studies and to validate our blebbistatin 
findings, we sought to investigate the individual contributions of NMII isoforms A and B 
(henceforth, NMIIA and NMIIB, respectively) in mediating the multicellularity of 
angiogenic sprouting achieved within our system.  Using CRISPR-Cas9-mediated gene 
editing, we generated MYH9 and MYH10 knockout endothelial cell lines (hereafter, 
IIAKO and IIBKO, respectively) (Figure 3.5A).  Immunofluorescence staining for 
NMIIA in IIAKO endothelial cells and NMIIB in IIBKO endothelial cells demonstrated 
reduction of isoform-specific myosin content (Figure 3.5B).  Strikingly, IIAKO 
endothelial cells appeared to possess more protrusive extensions and generated 
cytoplasmic fragments.  This morphology resembles that of blebbistatin-treated control 
cells (Figure 3.5C).  In contrast, IIBKO endothelial cells maintained basic physical 
features similar to that of the control cells, namely by retaining the broad lamellipodia 
characteristic of normal endothelial cells.  However, in some IBKO cells, retraction 
failure of the trailing tail can be observed.  Intriguingly, such phenotypic differences 
induced by knockdown of specific NMII isoforms has been demonstrated in other cell 
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To determine the functional roles of each NMII isoform in sprout morphogenesis, 
we introduced the IIAKO and IIBKO endothelial cells into our in vitro sprouting model.  
After 3 days of stimulation with a cocktail of angiogenic factors, the devices were fixed 
and analyzed for sprout morphology through immunofluorescence staining for CD31 
(Figure 3.5D).  Overall, perturbations to NMIIA and NMIIB had no significant effect on 
the overall capability of cells to invade, as measured by the number of cell nuclei found 
within the collagen matrix (Figure 3.5E).  These results are in line with that of Figure 1, 
where sprouting was triggered and sustained under blebbistatin treatment.  Intriguingly, 
whereas loss of NMIIB resulted in no significant changes to sprouting efficiency, as 
measured by the perpendicular distance between the leading tip of an intact sprout to the 
base of the sprout, loss of NMIIA led to a slight but significant reduction in sprouting 
efficiency (Figure 3.5F).  Most importantly, sprouting from IIAKO endothelial cells was 
characterized by an increase in the portion of cell-cell breakages, whereas loss of NMIIB 
led to no significant change in this regard (Figure 3.5G).  Taken together, these findings 
confirm our previous conclusions that NMII-mediated contractility is critical for 
maintaining multicellularity of angiogenic sprouts and highlight the distinct roles of 
NMIIA and NMIIB in sprouting, with the NMIIA isoform predominantly dictating the 





NMIIA is the main force-generating contractile unit in endothelial cells 
Based on these observed differences in the contributions of NMIIA and NMIIB to 
the multicellular morphogenesis of angiogenic sprouts, we hypothesized that the forces 
generated by sprouts earlier in Figure 3.1 would largely be dependent on NMIIA.  To test 
this hypothesis, we measured the displacement of fiduciary beads generated by sprouts 
formed within the in vitro angiogenesis model.  Indeed, we found that multicellular 
sprouts formed by IIAKO endothelial cells on average produced lower magnitude 
deformations on the surrounding matrix, as depicted in Figure 3.6A.  This loss of large 
bead displacements in the matrix surrounding the leading front of the IIAKO sprouts led 
to a shift towards smaller deformations in the overall frequency distribution of bead 
displacements as compared to the Scramble control sprouts (Figure 3.6B).  Analysis of 
the average bead displacement per sprout between the Scramble control and IIAKO 
sprouts did not yield statistically significant changes but follow the general trend that loss 
of NMIIA leads to a reduction in sprout-generated forces (Figure 3.6C).  In line with our 
previous findings suggesting a more limited role of NMIIB in sprouting, loss of NMIIB 
did not significantly alter the ability for multicellular sprouts to generate matrix 
deformations and cellular tractions.  This reduction in the ability of NMIIA-deficient 
sprouts to generate contractile forces is confirmed through 2D traction stress 
measurements of single cells (Figure 3.7), demonstrating that NMIIA is the main 
contractility generating unit in endothelial cells within both 2D and 3D settings.  Overall, 
the data presented in this work indicate that generation of cell contractility, namely 




chemotactic migration in the context of sprout morphogenesis. 
Figure 3.6: NMIIA is the predominant force-generating unit within multicellular 
sprout structures. (A) Example matrix deformations maps (colored arrows) generated 
by endothelial sprouts (grey).  (B) Each dot represents the magnitude of one 
displacement vector. The scatter plot is a compilation of N = 4-5 sprouts per condition.  
Only the vectors within 5µm of the sprout surface were considered for the analysis, and 
displacements over 5µm are not displayed on the graph.  (C)  The average bead 
displacement for each sprout in each condition are displayed.  Bars represent mean ± 
SEM. ****represents p < 0.0001 as determined by a Kruskal-Wallis test.  Statistical 







Extensive research investigating the functions of NMII in various cell types and 
contexts has demonstrated its role as a universal regulator of cell contractility and 
migration.  Despite the substantial growth in our understanding of how NMII orchestrates 
cell movements, there has yet to be a study that looks into the direct role of NMII in 3D 
sprout morphogenesis.  In this chapter, we explored this open area by addressing what we 
Figure 3.7: Loss of NMIIA leads to a significant reduction in two-dimensional cell 
generated traction stresses.  Representative traction stress field maps of individual 
CRISPR-modified cells.   The color and length of the arrows are directly correlated with 
the magnitude of stress (Pascals).  The red outline indicates the border used to determine 
which vectors would be included in the calculation for the root mean square traction 
stress values.  Each dot in the plot represents the RMS stress for one cell. N ≥ 33 cells 
from 3 independent samples. The mean ± SD are displayed.  **** represents p < 0.0001 




view as the two main limitations of existing studies examining contractility in 
angiogenesis.  First, we utilized a biomimetic 3D model of angiogenesis that captures 
several aspects of in vivo angiogenesis, including gradient-driven invasion triggered by 
pro-angiogenic factors and complete three-dimensionality of surrounding matrix.  
Secondly, we attained NMII-specific perturbation through the use of blebbistatin as well 
as CRISPR-Cas9 gene editing to exclude the potential for upstream mediators of NMII 
and the off-target effects of their inhibitors to confound our findings. We believe the 
combination of these two approaches enables a more rigorous study of how NMII 
contributes to collective migration and force generation during sprout morphogenesis.   
Using this experimental platform, we made two main observations.  First, we 
found that sprout morphogenesis is associated with contractile forces mainly exerted by 
the leader tip cells.  This observation is in line with notion that leader tip cells actively 
pull on the surrounding matrix while the following stalk cells likely interact more 
passively with the matrix during sprout elongation (Du et al. 2016, Korff & Augustin 
1999).  Unlike outward forces, which would most likely be observed in cases where 
migration is achieved by pushing the collagen fibers aside, the existence of pulling forces 
implies that cells must proteolytically degrade the ECM to create a path for migration.  In 
fact, many groups have shown that activity of matrix metalloproteinases (MMPs) is vital 
to enabling angiogenesis and expression of MT1-MMP is particularly localized to sprout 
tip cells (Chun et al. 2004; Yana et al. 2007).  In our system, it is possible that we 
observed larger matrix deformations at the tip cells of sprouts because of this MMP-




conclusion that tip cells are the predominant force-generating units within sprouts can be 
supported by studies which found that stimulation of endothelial cells with VEGF 
increases contractile forces and stress fiber formation (Yang et al. 2011; LaValley et al. 
2017).   
Secondly, based on our first observation, we anticipated that inhibiting 
contractility would halt sprouting angiogenesis.  However, we found that blocking cell 
contractility via treatment with blebbistatin ultimately did not hinder the invasiveness of 
endothelial cells.  This is in line with findings from other studies demonstrating that cell 
migration is not completely abrogated with impairment of cell contractility.  For instance, 
in 2D settings, epithelial cells are able to migrate at an even faster rate when expression 
of NMIIA is knocked down (Jorrisch et al. 2013).  Others have shown that in 3D, 
exposure to blebbistatin still permits random cell migration albeit at slower speeds 
(Fischer et al. 2009; Provenzano et al. 2008, Doyle et al. 2015).  We hypothesize that 
blebbistatin and knockdown of NMII expression within our particular system did not 
substantially impact overall invasion rate due to the chemotactic gradient of angiogenic 
factors used to drive sprouting.  More systematic studies to investigate the role of NMII 
in chemotaxis-driven invasion of endothelial cells would help to confirm this postulation 
and improve our basic understanding of angiogenic sprouting, given that most, if not all, 
instances of angiogenesis are thought to be gradient-driven. 
Instead of hindering migration, we observed that reduction in NMII activity led to 
the fragmentation of multicellular sprouts.  This metric of collectiveness, a critically 




vitro angiogenesis assays but has relatively recently been incorporated into more studies 
of sprout morphogenesis (Wimmer et al. 2012; Shin et al. 2011; Del Amo et al. 2016).  In 
this work, we observed that NMII-mediated contractility directly impacts cell 
cohesiveness and specifically found that blebbistatin-induced breakages preferentially 
occur between tip and stalk cells versus stalk and stalk cells.  This is likely in part due to 
the fact that, with blebbistatin treatment, a greater portion of tip-stalk adhesions take on 
the discontinuous junction phenotype, which is more prone to disassembly.  In support of 
this notion, a recent study has linked disorganized junction morphologies to adhesions 
between migratory cells at the migrating front in a scratch wound assay, whereas linear 
adhesions are observed in less dynamic settings, such as between cells in a quiescent 
monolayer (Cao et al. 2017).  Accordingly, treatment of collectively migrating 
endothelial cells with VEGF, a well-established disrupter of endothelial adherens 
junctions, enhances the number of cells that detach from the main cohort (Huveneers et 
al. 2012; Oubaha et al. 2012).  Along the same lines, a recent work published by Hayer et 
al. (2016) shows that when confluent monolayers of endothelial cells are treated with the 
ROCK inhibitor Y-27632, which has been shown to reduce adherens junction formation 
(Abraham et al. 2009), coordinated cell movements are severely diminished.  Taken 
together, our findings and previous work connecting junctional organization with cell 
dynamics and contractility support the notion that myosin-mediated cell contractility is 
necessary to maintain physical connectivity of endothelial cells including in the context 






CHAPTER 4: INVESTIGATING MELANOMA-VASCULAR INTERACTIONS 
THROUGH A CRANIAL WINDOW MODEL 
4.1 Introduction 
Melanoma, the malignant proliferation of the pigment cells melanocytes, is the 
most aggressive form of skin cancer and accounts for about 75% of skin cancer-related 
deaths (Schadendorf et al. 2015).  Its aggressiveness derives in part from the high 
propensity for melanoma tumors to metastasize, even in cases when the primary tumor is 
relatively small in size (Sandru et al. 2014).  In fact, in patients with advanced cases of 
metastatic melanoma, life expectancy drops to 6 to 9 months (Gogas et al. 2006).  Most 
frequently, melanoma metastases are found within other regions of the skin as well as the 
lymph nodes, central nervous system, and lungs (Sandru et al. 2014).  As part of the 
metastatic cascade, tumor cells often form interactions with the vasculature in order to 
gain access to the circulatory system.  Though there have been many studies aimed at 
identifying the physical and molecular mechanisms that drive melanoma interactions with 
the vasculature and endothelial cells, many questions regarding the relationship between 
these heterotypic interactions and metastasis still remain open. 
Intriguingly, while several studies have associated cancer cell infiltration into 
blood vessels with an increased risk for metastasis, observation of melanoma cells within 
the circulation is rare (Van Es et al. 2008).  Instead, histological evaluation of samples 
from patients with melanoma have demonstrated a unique manner in which malignant 
cells interface with vascular structures.  This phenomenon, coined angiotropism, involves 




of local metastases and diminished disease-free survival (Van Es et al. 2008).  Additional 
clinical studies have also found associations between angiotropism and the presence of 
microscopic satellites, which are small micrometastases found in the periphery of the 
primary melanoma.  Interestingly, separate studies have shown that the presence of 
microscopic satellites in histological samples predicts diminished patient survival and 
even the establishment of distant metastases (Wilmott et al. 2012).  Together, this 
growing body of research around angiotropism in melanoma suggests the importance of 
melanoma-vascular interactions in advancing disease progression and lethality. 
Despite the clinical implications of angiotropism in melanoma patients, 
investigation into the detailed processes and dynamics surrounding melanoma-vascular 
interactions have been limited, given that this phenomenon has largely been studied 
through histological samples.  Recently, several groups have established in vitro and in 
vivo systems to examine angiotropism in greater detail.  For example, in this work by 
Fornabaio et al. (2018), the authors utilized an endothelial network formation assay and 
co-cultured the vascular structures with different melanoma cell lines to demonstrate that 
malignant melanoma cells migrate faster on endothelial structures than do non-malignant 
melanocytes.  Using a zebrafish model, these authors also demonstrated the ability to 
track the movement of melanoma cells along vascular structures.  In addition to these 
platforms, a murine brain model for melanoma angiogtropism has been established 
(Bentolila et al. 2016).  The authors found that xenografted metastatic melanoma cells 
which have disseminated into the brain closely interact with the brain vasculature and 




important revelations, it still remains unclear as to the specific advantage angiotropism 
affords melanoma cells in the process of establishing metastases.  Based on extensive in 
vitro studies investigating the impact of constrained settings, substrate topography, and 
two-dimensional (2D) versus three-dimensional (3D) environments on the ability for cells 
to migrate (Ray et al. 2017, Werner et al. 2018, Wu et al. 2013, Fallica et al. 2012), we 
hypothesize that, in vivo, the interface between tissues and the vasculature 
topographically provides a more constrained, planar-like substrate on which to melanoma 
cells are able to migrate.  Given that 2D migration is known to enable faster cell 
migration in vitro in a variety of cell types including cancer cells (Wu et al. 2013, Fallica 
et al. 2012), we posit that melanoma-vascular interactions enable cancer cells to more 
quickly spread from the primary tumor site and thereby possibly enhance the likelihood 
of micrometastases establishment and recurrence of the primary tumor even after 
resection.   
To this end, in this chapter, we discuss the establishment of a novel cranial 
window model for monitoring the dynamics of cancer-vascular interactions.  Broadly 
speaking, in this platform, we are able to identify strong angiotropic behaviors of 
metastatic melanoma cells, consistent with previous findings from other groups.  
Additionally, we were able make preliminary observations through the use of live, 
multiphoton microscopy techniques that melanoma cells interacting with vascular 
structural indeed exhibit enhanced migration speeds when compared to cells found within 
the primary injection site in the parenchymal space.  The preliminary work outlined in 




pathways involved in 2D versus 3D migration.  Additional studies designed to distinguish 
these two modes of migration may aid in demonstrating that this key switch in migration 
machinery within angiotropic melanoma cells may enable tumors to ultimately spread 
more rapidly.    
 
4.2 Materials and Methods 
Cell culture:  GFP-labeled 1205Lu metastatic melanoma cells were a generous 
gift from Dr. Rhoda Alani (Boston University School of Medicine).  Cells were cultured 
in high glucose Dulbecco’s Modified Eagle Medium (Corning) supplemented with 10% 
fetal bovine serum (Hyclone, Fisher), 2mM L-glutamine (Gibco), and 1% penicillin-
streptomycin (Gibco).  Cells were maintained in a humidified incubator at 37°C and 5% 
CO2.  
Image acquisition and processing:  All fluorescence images were acquired with 
an upright Leica TCS SP8 multiphoton microscope equipped with a Spectra-Physics 
Insight DS+ laser.  ImageJ (NIH) was used to merge channels, perform Z-projection for 
all confocal stacks, stitch images, and perform drift correction on images obtained from 
time-lapse experiments. 
Cranial window installation and cell injection: For installation of the cranial 
window, mice were anesthetized with 1-4% isoflurane and immobilized with a stereotaxis 
apparatus, with ear bars and a nose holder and/or bite bar.  Once fully anesthetized, the 
top of the mouse’s head was shaved and sterilized the skin 70% alcohol and 7.5% 




and retracted laterally using a self-retaining retractor (WPI, 501968). To prepare the 
cranial surface, a solution of 3% hydrogen peroxide was applied to oxidize and facilitate 
removal of periosteal tissue with cotton tip swabs. 
The headplate was anchored directly to the skull using semi-clear quick adhesive 
cement (Parkell, S380). Subsequently, the craniotomy was completed by drilling along 
the edges. Once separated from the surrounding skull, the bone flap was carefully 
removed while keeping the dura intact.  Injections of melanoma cells were made using 
pulled glass micropipettes with inner tip diameter ranging from 40 and 80um (WPI, 
504949). The micropipette was front-loaded with cells using a controller (WPI, Sys-
Micro4), and an injection of 230nL of cells was performed approximately 500um deep 
into the cortex at the rate of 46nL/min.  The optical insert attachment was performed 
immediately following the injection, filling the headplate chamber with sterile 0.5% 
agarose solution. The window was placed in the chamber, directly over the craniotomy, 
in gentle contact with the exposed tissue. We used bolts and nuts to adjust the window 
height and secure its position.  
Immunofluorescence staining and microscopy of cranial tissue samples:  One 
week after cranial window surgery and injection of melanoma cells, mice were sacrificed 
by cervical dislocation. The brain tissue was harvested and fixed with 4% formalin at 4°C 
overnight before washing with PBS.  The brain vasculature was stained using a Rabbit 
anti-Collagen IV antibody (1:300; AB6586; Abcam) and Goat anti-rabbit secondary 
antibody (1:300; Alexa Fluor 647 A27040; Invitrogen).  Whole-mount samples were 




Dorsal subcutaneous xenograft of melanoma cells:  Two million 1205Lu-GFP 
cells were resuspended in 1:1 mixture of cancer cell growth medium and high 
concentration Matrigel (Corning) and a total volume of 100 µL was subcutaneously 
injected into an athymic nude mouse (Taconic, NCr-nu/nu, female) using an insulin 
syringe.  Two weeks after tumor injection), the animal was euthanized using carbon 
dioxide followed by a cervical dislocation, and the tumors and surrounding skin were 
excised for immunohistology.  
Immunofluorescence staining and microscopy of subcutaneous samples:  
Excised tumors were rinsed in PBS and fixed in 4% PFA for 20 hrs at room temperature. 
Fixed samplers were placed in 30% sucrose solution in DPBS for 3 days at 4°C, and 
frozen in Tissue-Tek Optimal Cutting Temperature (O.C.T.) compound (Sakura). 
Sections of 10-µm thickness were cut at -20°C.  Sections were stained with the following 
primary antibodies: Rabbit anti-collagen IV (1:100; ab6586; Abcam), Rat anti-mouse 
endomucin (1:100; sc-65495; Santa-Cruz).  Secondary antibodies included: Goat anti-
GFP antibody (1:500; Fluorescein isothiocyanate (FITC) ab6662; Abcam), Goat anti-rat 
antibody (1:500; Rhodamine; Jackson ImmunoResearch), and Goat anti-rabbit antibody 
(1:500, Alexa Fluor 647; Jackson ImmunoResearch).  Samples were imaged on the Leica 
multiphoton microscope using the laser scanning confocal setting.   
Live multiphoton imaging through the cranial window model: For intravital 
imaging, mice were anesthetized using an isoflurane nebulizer, injected with 100uL of 7 
mg ml-1 dextran (2,000 kDa; Invitrogen) labeled with Tetramethylrhodamine (TRITC) 




stage using a custom-designed head-plate holder.   Images of the 1205Lu-GFP cells and 
the TRICT-labeled vasculature were obtained with a Leica HCX APO L 10x/0.30 W 
immersion objective and laser tuned to 850 nm excitation. GFP emission was detected 
using a HyD-RLD 2ch DAPI/FITC filter cube and TRITC was detected using a HyD-
RLD 2ch TRITC/A633.  
 
4.3 Results 
1205Lu-GFP metastatic melanoma cells robustly associate with vascular structures in the 
brain and skin 
While the ultimate focus for this project is to study the dynamics of cancer cell 
migration in the brain, particularly along vascular structures, we first sought out to 
determine how our model cell line, 1205Lu metastatic melanoma cells, behaves in in vivo 
settings.  Based on previous work by other groups studying angiotropic behaviors of 
other melanoma cell lines in various in vitro and in vivo settings, we hypothesized that 
1205Lu cells would also initiate such interactions with the vasculature (Fornabaio et al. 
2018, Bentolila et al. 2016).  To test this hypothesis, we introduced 1205Lu-GFP cells 
into the brain of an immunocompromised mouse using the same techniques that would 
later be used to inject these cells into the brain in future studies using the cranial window 
model, via microinjection using a pulled glass micropipette.  One week after cell 
injection, the tissue was harvested, stained for vascular structures (through staining for 
collagen IV found in the vascular basement membrane), and imaged using confocal 




From this sample, we made several key observations.  First, we noted that the 
technique used for introducing the 1205Lu cells into the mouse brain did not obviously 
affect the viability of the cells and therefore permitted the formation of a tumor mass at 
the main injection site (Figure 4.1A).  Beyond the margins of the primary site of 
injection, we observed that numerous cancer cells had escaped and traveled distances of 
up to 500µm from the tumor border (Figure 4.1A).  Upon closer inspection at higher 
magnification, we observed that the majority of the cancer cells which escaped were 
found in close proximity to vascular structures, thereby supporting our hypothesis that 
1205Lu cells will display angiotropic properties in vivo (Figure 4.1B).  Intriguingly, 
through ultra-high magnification imaging, we were also able to observe the protrusion-
like structures generated by some of the cells interacting with vessels (Figure 4.1C).  
Surrounding the protrusions of these cells, we noticed the remnants of small GFP+ cell 
fragments co-localized with collagen IV staining, which we posit were generated by 







Since the brain is not the predominant site where primary melanomas can form, 
we chose to validate these findings in more biologically relevant setting.  To this end, we 
injected 1205Lu-GFP cells into the dorsal subcutaneous site of an immunocompromised 
mouse and, two weeks later, collected the skin at the primary injection site as well as the 
Figure 4.1:  Metastatic melanoma (1205Lu-GFP) cells robustly associate with 
vascular structures in the brain and skin. (A) Low magnification fluorescence image 
demonstrating dissemination of GFP-labeled melanoma cells (green) from the primary 
injection site into the vascularized (red) brain parenchymal tissue. Scale bar is 200µm. (B) 
High magnification fluorescence image illustrating clear melanoma-vascular interactions 
in the brain. Scale bar is 100µm.  (C)  Ultra-high magnification fluorescence image 
showing direct interactions of melanoma cells with the brain vasculature.  Small 
protrusion-like structures can be visualized at this magnification. Scale bar is 20µm.  (D) 
Low magnification fluorescence image demonstrating invasion of 1205Lu-GFP cells 
(green) from the primary injection site into the vascularized skin (red). Scale bar is 
200µm.  (E) High magnification fluorescence image depicting vascular-melanoma 
interactions. Scale bar is 100µm.  (F) Ultra-high magnification fluorescence image 
demonstrating flattened morphology of 1205Lu cells interacting with the vasculature. 




surrounding region for immunofluorescence staining and imaging.  Though the border of 
the tumor formed at the primary injection site was much less discernable than that which 
was observed in the brain, we nonetheless observed migration of the melanoma cells 
away from the main tumor site (Figure 4.1D).  In line with our findings in the brain, we 
observed association of melanoma cells to the skin vasculature (Figure 4.1E).  
Interestingly, upon higher magnification imaging, we were able to appreciate the 
flattened cell morphology of many cells interacting with the skin vasculature (Figure 
4.1F), a phenomenon which can also be appreciated in Figure 4.1C.   
Through these studies, we have established that our model metastatic melanoma 
cell line, 1205Lu, displays angiotropic behaviors in the brain and skin.  Our observations 
that much of these interactions can be seen peripheral to the primary tumor injection site 
and that those cells which are interacting with vascular structures tend to take on a more 
flattened morphology both support our hypothesis that melanoma cells migrate in a more 
2D-like fashion along vessels in order to more rapidly invade to new tissue sites.   
 
A cranial window model for intravital imaging of metastatic melanoma cells in the brain 
Given our findings from these tissue samples, we moved forward with development of 
the cranial window model in order to study the dynamics of these cancer-vascular 
interactions.  This window model, developed by the Han Lab in the Department of 
Biomedical Engineering at Boston University, involves the surgical exposure 
(craniotomy) of the two brain hemispheres and installation of a custom designed and 3D-




and the elastomeric, optically clear window insert. The head plate, which serves as the 
base of the window, is installed over the region of the skull where the craniotomy was 
completed.  Subsequently, the second, elastomeric portion of the window is placed over 
the exposed cranial tissue and secured onto the head plate with two small screws (Figure 
4.2B).  In this way, this piece of the window can be removed after installation particularly 
in cases where further manipulations to the animal are required at a later time (e.g. adding 
pharmacological drugs, viruses, different cell types).   
Figure 4.2:  A cranial window model designed to interface with an upright 
multiphoton microscope for intravital imaging.  (A)  Image of the cranial window, 
assembled and installed, onto a mouse that has undergone craniotomy surgery to 
reveal both hemispheres of the brain.  Pictured are the optically clear window regions, 
the custom 3D-printed head plate, and the head plate stabilizing mount.  (B)  Zoomed-
in view of the window regions demonstrating a clear view of the brain tissue and 
vascular structures. Small screws are used to secure the window to the head plate.   
(C) Image of a mouse with an installed cranial window, positioned on the stage of the 
multiphoton microscope.  The stage is heated and supplied with anesthesia and 
oxygen lines, and the head plate stabilizing mount pictured in (A) is used to secure the 




 The dimensions of the window have been optimized to interface with an upright 
two-photon microscope built for intravital imaging.  This allows for imaging of structures 
deeper in tissues and enables concurrent visualization of fluorophores of multiple 
wavelengths.  In Figure 4.2 C, a mouse with a cranial window installed is seen on the 
microscope stage.  The stage is equipped with a veterinary heat pad and an environmental 
chamber that both help to maintain the temperature of the animal during imaging sessions 
as well as anesthesia/oxygen lines to retain the mouse under sedation throughout the 
imaging period.  At the stage, the mouse is secured to the microscope stage with the head 
plate stabilizing mount also pictured in Figure 4.2A.  This mount enables the animal to 
stay at a fixed location and prevents large movements of the head caused by breathing 
motions.  Such positional stabilization is of utmost importance especially in studies 
involving the tracking of individual cell movements at high magnification.  
 
Time-lapse imaging of individual melanoma cell reveals highly dynamic movements 
along blood vessels 
 In light of our interest in studying migration of cells along vascular surfaces, we 
tested whether the cranial window imaging platform described above could support 
frequent image acquisition of motile cancer cells and the vasculature.  Five days after 
window installation and melanoma cell injection, we began intravital imaging through the 
window, using TRITC-labeled high molecular weight dextran to visualize vascular 
structures.  In this animal, we were able to identify a single melanoma cell migrating 




(Figure 4.3A).  By capturing a z-stack of this region and using orthogonal views, we 
confirmed that this cell indeed co-localized with the vessel below it.  Notably, this cell 
was also seen to take on a similar morphology to that which is shown in Figure 4.1C, 
including the presence of polarized protrusive structures at one end. We acquired images 
of this cell moving along the vascular surface every 10 minutes for 1 hour and observed 
remarkable changes to the cell shape and the protrusions at the leading front of the cell 
(Figure 4.3B).  By calculating the net displacement of the centroid of the cell body, we 
estimated this cell to move at approximately 35µm/hour. 
 
 Using this system, we are not only able to locate and measure the movement of 
Figure 4.3:  Time-lapse imaging of cancer cell reveals dynamic movements along 
vascular structure.  (A) Z-projection image of metastatic melanoma cell (green) 
interacting with a blood vessel (red), 15 minutes after injection of TRITC-dextran into 
the circulatory system.  The orthogonal XZ view demonstrates the close proximity of the 
cancer cell and vessel. Scale bar is 25µm.  (B)  Sequential images of cancer cell (green) 
and vessels (red), taken every 10 minutes, highlights the dynamic movements of the 




individual cells but are also able to clearly visualize the structure of the vasculature 
during this time.  Over the course of this imaging session, no appreciable loss of signal 
intensity or diffusion of the dextran out of the vasculature was observed.  Due to these 
features, we are able to monitor cancer cell-vascular interactions during this time period 
and also use the vascular structures as fiduciary structures to correct for small, micron-
scale shifts in the imaging region of interest that occur over time. 
 
Multi-day intravital imaging demonstrates ability for cancer cells to migrate long 
distances along vascular structures 
 In addition to determining if this imaging system could support short-term time-
lapse imaging sessions as was described in Figure 4.3, we also sought to test whether 
several imaging sessions over multiple days could be accomplished.  To this end, we 
monitored the progression of cancer cell movement over two days, from Day 2 to Day 4 
after window installation and injection of the melanoma cells.  On Day 2, we captured 
initial images of the injection site and found a that small tumor with relatively well-
defined borders had formed in the region (Figure 4.4A).  On the subsequent day, Day 3, 
TRITC-dextran was injected into the circulation via retro-orbital injection and the same 
tumor mass was located (Figure 4.4B).  While much of the tumor formed at the injection 
site remained contained to its original location, we observed a stream of 1205Lu-GFP 
cells utilizing a nearby vascular structure to migrate away from the primary site.  Based 
on our initial image of the injection site, we estimated this cohort of cells to have 




introduced another bolus of TRITC-dextran retro-orbitally to the animal and located the 
tumor at the injection site.  Strikingly, we observed that this cohort of cells continued on 
its trajectory, having migrated approximately 100µm further (Figure 4.4C).  In this same 
time frame, we estimated that the border of the tumor at the primary injection site only 
advanced ~30-40µm. 
Figure 4.4:  Multi-day monitoring of melanoma cells through the window model 
illustrates that interactions with vascular structures can enhance migration away 
from the primary site.  (A) 1205Lu-GFP cells injected into the brain form a cohesive 
mass on Day 2 after cranial window installation surgery and injection of cancer cells. 
Scale bar is 100µm. (B-C) Cancer cells are seen to migrate away from the primary 






In this chapter, we described the adaptation of a cranial window model for 
studying melanoma metastases in the brain through collaborative efforts with the Han 
Lab in the Department of Biomedical Engineering at Boston University.  Though 
melanoma does not chiefly originate in the brain, we chose the brain as the model organ 
for our studies due to the tendency for melanoma to metastasize to the brain.  In fact, of 
all the different types of cancer that are known to form brain metastases, melanoma holds 
the highest propensity (Sandru et al. 2014; Glitza Oliva et al. 2018).  Through the work of 
this chapter, we have demonstrated the ability to monitor cancer-vascular interactions at 
both low and high magnification, allowing us to begin gaining a global and more detailed 
understanding of these physical interactions.  Moreover, we have demonstrated that this 
platform enables dynamic observation of angiotropic cancer cell migration at high 
frequency over short periods of time as well as across multiple days.  Importantly, 
because of these abilities, we have been able to gather preliminary evidence suggesting 
that vascular interactions enable more rapid dissemination of cancer cells from their 
primary site. 
 Intriguingly, melanoma cells have historically been recognized to interact with 
various interfacial structures found within the body.  For instance, melanoma cells are 
strongly found to engage with perineurium layers that encase bundles of axons within 
nerve structures (Van Es et al. 2008).  Like angiotropism, this phenomenon known as 
neurotropism is associated with decreased survival and enhanced incidence of local 




have been robustly observed during physiological processes as well as pathological cases 
related to the central nervous system.  In stages of early embryo development, for 
instance, neural crest cells are known to quickly migrate from the neural tube along 
interfacial regions defined by the basement membrane of the dermomyotome (Krull 
2001, Theveneau & Mayor 2012).  During neurogenesis, close interactions between 
neuronal precursor cells and vascular structures have also been established.  Researchers 
have found through high-resolution and time-lapse microscopy that vessels in the 
developing brain are encased with neuroblasts and that these cells are able to move along 
these structures to arrive at their final destinations (Segarra et al. 2015).  Pathologically, 
malignant gliomas have been studied in the context of vascular-guided migration.  In fact, 
using rodent models of brain cancer, several groups have shown that glioblastoma cells 
located near vascular structures of the brain indeed migrate at a greater velocity than 
those found in the parenchymal space (Winkler et al. 2009, Hirata et al. 2012).  Given 
that melanocytes and cells of the central nervous system both developmentally arise from 
the neural crest, it is plausible that the inclination to use interfacial surfaces for migration 
seen in melanoma and many other neural/neuronal developmental and pathological 
processes are biologically linked (Theveneau & Mayor 2012).  More in-depth studies to 
investigate the overlapping molecular machinery involved in the migration of these 
various cell types and settings may shed more light on the regulators of this angiotropic 
phenomenon.  A more detailed discussion of next steps and potential future directions in 
regard to dissecting some of the molecular pathways involved in this phenomenon is 




Though research into angiotropic interactions is relatively nascent, several other 
in vivo approaches have recently been employed to study this phenomenon.  In Fornabaio 
et al. (2018), for example, the authors utilize zebrafish as their model organism and 
demonstrate that implanted melanoma cells are able to interact with and migrate along 
the intersegmental vessels of the trunk.  While this model allows for high-resolution 
intravital imaging of vascular structures and cancer cells, the microenvironment in which 
these interactions are being studied have low clinical and translational relevance.  In other 
studies, groups have used the rodent brain to study these interactions, particularly using 
melanoma and glioblastoma cell lines (Bentolila et al. 2016, Hirata et al. 2012).  
However, angiotropic behaviors were studied through immunohistological analysis of 
fixed tissues or live imaging of excised brain slices.  Both of these approaches have major 
drawbacks and limitations, particularly by not allowing for real-time monitoring of 
cancer-vascular interactions in the former study and by introducing a plethora of 
confounding environmental factors in the latter.  The cranial window described in this 
chapter provides several advantages over these other in vivo systems and thus may be a 
better suited system for probing more mechanistic questions related to the dynamics of 
angiotropic migration.   
 





CHAPTER 5: SUMMARY AND PERSPECTIVES 
5.1 Chapter 2 
5.1.1 Summary and future directions 
In Chapter 2 of this dissertation, the role of Notch signaling in mediating cell-
matrix interactions was investigated using classical 2D traction force microscopy 
techniques.  Through this assay system, we observed that inhibition of Notch signaling 
via treatment with the inhibitor DAPT led to a reduction in cell-generated tractions.  This 
was accompanied by a reduction in focal adhesions, as demonstrated through 
immunofluorescence staining for the focal adhesion protein paxillin.  Based on these 
findings and previous literature, we hypothesize that in baseline conditions, without shear 
stress stimulation, Notch signaling may prime endothelial cells to react to barrier 
enhancing factors and may enable more rapid barrier stabilization after disruption.  With 
DAPT treatment, endothelial cells may be slower or unable to react to various 
permeability modulatory stimuli.   
In the future, work to validate the findings presented in this chapter and to pursue 
these hypotheses will be necessary.  To determine whether Notch signaling directly 
affects cell adhesiveness to substrates, studies evaluating cell attachment in the presence 
of or after pre-treatment with DAPT may be an interesting start.  Additionally, evaluation 
of the phosphorylation status of other proteins known to localize to integrin-based focal 
adhesions such as FAK and talin through western blot analysis would be of particular 
interest.  To probe whether basal levels of Notch signaling enable faster responsiveness to 




we propose to use transendothelial electrical resistance (TEER) assays on cells which 
have been pre-treated with DAPT or the vehicle control.  TEER may be a suitable 
experimental platform for probing this hypothesis since it enables for fast, real time 
measurements of barrier function over time.  Based on our postulations, we may expect to 
see more rapid drops in resistance values or slower recovery of barrier resistance from 
DAPT pre-treated cells that are exposed to permeability inducing compounds like 
thrombin or histamine.   
In the discussion section of Chapter 2, we also highlight the possibility that the 
effects of DAPT may also be mediated through cell-cell adhesions.  As such, experiments 
investigating the impact of DAPT on patterns of individual cells instead of multicellular 
cohorts would be revealing.  If similar magnitudes in traction stress changes are observed 
in single cells, it is likely that DAPT’s effects are conveyed through cell-matrix 
interactions.   If no changes to traction stresses are observed with DAPT treatment in this 
scenario, it would support the alternative that the regulation of substrate tractions is likely 
occurring through cell-cell contacts.   
5.1.2 General limitations of this work 
 The work in this chapter solely revolves around the use of the small molecule 
inhibitor DAPT to interfere with Notch signaling.  In many other works studying Notch 
signaling in endothelial cells, this drug has been utilized as a reliable inhibitor of Notch, 
both at short and long time scales (Polacheck et al. 2017, Zheng et al. 2017, Hellstrom et 
al. 2007).  In our system, DAPT treatment was limited to around 45-90 minutes in order 




have on cell-cell and cell-matrix interactions.  Treatment with DAPT on these time scales 
have previously been shown to elicit changes to endothelial barrier function (Polacheck et 
al. 2017).  The use of DAPT was also strategically chosen in order to eliminate the large 
variability in traction stresses observed between different patterned endothelial regions.  
By directly measuring traction stresses of each pattern before and after treatment, a more 
rigorous analysis of DAPT’s effect was probed.  However, as with many small molecule 
inhibitors, DAPT is known to affect many other signaling pathways.  Given that DAPT is 
an inhibitor of γ-secretase, an enzyme involved in releasing the cytoplasmic domain of 
the Notch receptor upon activation, and not of the Notch receptor specifically, off-target 
effects may be even more likely to occur.  For instance, over 50 other membrane-bound 
receptors have been identified to have amino acid sequences that can be substrates for γ-
secretase cleavage (Beel & Sanders 2008).  Thus, it is entirely possible that some of the 
effects we observed are the result of DAPT off-target effects.  In the future, side-by-side 
studies including cells with repressed expression of the Notch1 receptor would be 
required to confidently suggest that observations are linked specifically to modulation of 
Notch signaling.  As was presented in Polacheck et al. (2017), additional comparison 
studies with cells expressing dominant negative Mastermind-like, which in its wild type 
form facilitates Notch transcriptional regulation, will be useful to distinguish 
transcriptional and non-transcriptional effects.   
 As was mentioned in the discussion section of Chapter 2, the system we presented 
in this chapter is based off of static culture and does not include laminar shear stress, 




endothelial cells under shear stress conditions would be more biologically relevant, as the 
endothelium in our vasculature is constantly exposed to blood flow.  Thus, while the 
studies presented here and suggested future work in this area would give more insight 
into the potential impact Notch signaling has in endothelial cells at baseline, adaptation of 
these experiments to enable controlled fluid flow would be advantageous.  Systems such 
as those described in Perrault et al. (2015) and Galie et al. (2015) would be particularly 
suitable given that they combine polyacrylamide substrates which can be used for traction 
measurements with control of fluidic flow.   
5.1.3 Broader implications of these findings 
While the studies described in this work report preliminary findings, future work 
to investigate the proposed hypotheses would shed new light on the ways in which Notch 
signaling operates at baseline levels within endothelial cells to facilitate proper barrier 
function.  If the hypotheses set forth from our observations are validated, these findings 
would suggest new mechanisms by which Notch signaling is linked to cell-matrix 
interactions, which may ultimately dictate barrier integrity.  More in-depth understanding 
of how various signaling pathways affect endothelial permeability are of utmost interest, 
especially with regard to treatment of pathological conditions and drug development.  
Beyond potentially impacting vascular conditions like retinopathy, Notch 
signaling has also emerged as a target pathway for other pathological conditions like 
cancer.  Particularly, in the treatment of cancers, Notch inhibitors such as γ-secretase 
inhibitors have been utilized to thwart tumor development by slowing cancer 




direct connections between disease pathology and Notch signaling have been established, 
but the activity of γ-secretase itself has been of most interest to the field, given that this 
enzyme also participates in the breakdown of amyloid precursor proteins.  In both of 
these situations, treatments aimed at inhibiting Notch/γ-secretase activity have been 
highly sought after.  However, in certain cases, treatment with such therapeutics has been 
linked to edema and exacerbation of other conditions linked to hyperpermeability of 
vessels like psoriasis (Brzozowa et al. 2013, Wagner et al. 2017, Aprahamian et al. 2013).  
As such, developing a greater understanding of the ways in which Notch signaling affects 
physiological vascular function may aid in the generation of more well-designed disease 
treatments.  
 
5.2 Chapter 3 
5.2.1 Summary and future directions 
In Chapter 3 of this dissertation, the role of myosin-mediated contractility in 
sprouting morphogenesis was probed using various in vitro tools as well as a mouse 
retina model of angiogenesis.  Through these studies, we have demonstrated that 
contractility is vital for maintaining multicellularity during 3D angiogenesis and have 
specifically shown that the NMII isoform NMIIA is the contractile motor unit largely 
responsible for preserving proper sprout morphogenesis.  To our knowledge, this is the 
first study to show that contractility and NMIIA play such a role in this context.   
Based on our characterization of cell-cell junctions and their morphological 




cell junctions through cell contractility is required for collective migration during 
sprouting.  While recent studies have emerged to support our observations and this 
postulation, it will still be critical to validate this proposed mechanism within our system 
given that cellular behavior is often context dependent.  Thus, in the future, studying 
changes in sprout morphogenesis in response to chemical perturbations and genetic 
manipulations to junctional components will help to test this hypothesis.  For example, 
treatment of sprouts with a VE-cadherin blocking antibody would help to determine 
whether targeted loosening of cell-cell junctions is directly linked to enhanced cell-cell 
breakages.  Since NMII acts directly in concert with the actin cytoskeleton of the cell, 
future studies looking at mechanisms through which actin interacts with cell junctions 
will also be useful.  Particularly, stabilization and active remodeling of endothelial cell 
junctions has been linked to the junctional localization of vinculin, a protein shown to 
link the actin cytoskeleton to a-catenin and the intracellular domain of VE-cadherin (Abu 
Taha & Schnittler 2014).  In fact, it has been shown that vinculin’s ability to engage at 
cell-cell junctions protects the disruption of these junctions caused by agents like 
thrombin and TNF-a, and that inhibition of actomyosin contractility abolishes the 
presence of vinculin at the junctions (Huveneers et al. 2012).  It would be interesting to 
test whether vinculin’s ability to maintain cell-cell junctions under conditions that 
involve dynamic remodeling is at play within our system.  For instance, it is possible that 
with blebbistatin treatment, vinculin is no longer recruited to active cell-cell adhesions 
and this in turn allows for cells within a sprout to more easily disassociate as they 




With respect to the nature of forces generated by multicellular sprouts, we have 
demonstrated that the majority of large matrix deformations generally occur at the 
leading front of the sprout around the tip cell.  While this is not necessarily a novel 
finding, as other evidence exists to show that contractile forces are generated by invading 
endothelial cells (Du et al. 2016, Korff & Augustin 1999), it serves to support the notion 
that sprout elongation at the leading front is largely mediated by pulling forces generated 
by the sprout and to establish the basis for manipulating cell contractility during 
sprouting within our unique system.  To attain these deformation measurements in our 
system, spatially isolated sprouts were studied in order to ensure that any recorded 
deformations are strictly due to the cells within the sprout in question and not other cells 
in the vicinity.  However, in biological settings, new sprouts do not form in isolation and 
instead grow to form network structures capable of circulating blood.  As such, sprouts 
can form in close proximity to each other and undergo natural events such as anastomosis 
and pruning (Adams & Alitalo 2007).  Future studies to investigate how sprouts interact 
with the ECM during these processes would shed more light onto the mechanical events 
that are at play in the full cascade of capillary network formation through sprouting.    
5.2.2 General limitations of this work 
Though the studies in Chapter 3 have elucidated the mechanisms through which 
NMII-mediated cell contractility enables multicellular sprout morphogenesis, there are 
limitations to these studies.  One particular limitation is that our model system employs a 
reductionist approach to recapitulating angiogenesis. Despite the fact that many important 




apical/basal polarization of endothelial cells, there are still many factors missing from 
this system (Nguyen et al. 2013).  One critical parameter is the involvement of other cell 
types, namely pericytes, during sprouting.  It has been widely appreciated that pericytes 
ensheath portions of capillary vessels and are recruited to new capillary structures during 
sprouting (Adams & Alitalo 2007).  It is possible that these cells, which have been shown 
to demonstrate contractile properties, can alter the contractile behavior of endothelial 
cells particularly in the stalk (Lee et al. 2010).  Incorporation of these cells into the 
sprouting system through sequential seeding of pericyte-like cells and endothelial cells as 
described in Alimperti et al. (2017) could help to answer more in-depth questions 
regarding the role of pericytes in sprouting morphogenesis and matrix interactions.  
Secondly, as mentioned in the discussion section of Chapter 3, it is possible that 
weakening of the matrix surrounding the tip cell is contributing to the observation of 
larger deformations around tip relative to the stalk of the sprout.  Unfortunately, in our 
system and many other assays for 3D bead tracking and traction force microscopy, this 
artifact is difficult to avoid considering most cells degrade the matrix in order to properly 
spread and move within its embedded matrix. However, in our system given that the stalk 
cells are following along the degraded path produced by the tip cell, it is possible that the 
matrix surrounding the stalk cells also have already been weakened by tip cell-generated 
MMPs to a certain degree, though the extent to which this may have happened is not 
validated.  Additional studies using our system to investigate the temporal evolution of 
matrix deformations generated by sprouts would aid in establishing a more holistic 




5.2.3 Broader implications of these findings 
The studies presented in Chapter 3 of this dissertation dive into more basic 
biological questions surrounding sprouting angiogenesis.  Understanding the fundamental 
mechanisms that drive angiogenesis may aid in our ability to control and treat 
pathological conditions in which angiogenesis is dysregulated, as is in cancers.  However, 
we also hope that the findings of this work will help to inform the field of important 
parameters to consider in cases where proper angiogenesis is desired.  Particularly in the 
field of tissue engineering and regenerative medicine, the formation of perfusable 
capillary networks within implanted or implantable constructs is highly desirable given 
that a lack of appropriate nutrient and oxygen supply can severely reduce the viability of 
tissues (Sekiya & Shimizu 2017).  In these instances, it would be ideal to intentionally 
choose the system parameters such that successful vascularization can be achieved.  One 
parameter, for example, which has been shown to directly affect cell contractility is the 
stiffness of the ECM.  In endothelial cells, it has been shown that mechanical stiffness of 
the substrate on which they are cultured is directly linked to the magnitude of force that 
they generate (Califano & Reinhart-King 2010, Huynh et al. 2011).   As such, alterations 
to the matrix stiffness of materials to be vascularized could directly affect the 
morphogenic phenotype of new vascular structures formed within engineered tissues.  
Additional studies to investigate the impact of ECM mechanical properties on 3D 
endothelial cell contractility and sprout morphogenesis could help to elucidate the 





5.3 Chapter 4  
5.3.1 Summary and future directions 
In Chapter 4 of this dissertation, we described the application of a novel cranial 
window model for studying melanoma-vascular interactions within the brain.  We 
demonstrated the ability for this system to support both short-term and multi-day studies 
of angiotropic migration of metastatic melanoma and found preliminary evidence 
suggesting that migration along the vasculature enhances the rate at which invasive cells 
escape from the main tumor site over time.   
Given the critical optimization and proof-of-concept results achieved through the 
work in this chapter, future work to shed light on the drivers of migration along vascular 
structures, compared to migration through the parenchymal space, are now possible.  
However, immediate follow-up studies that are focused on replicating and quantifying the 
observations we have made in this chapter are required and already underway.  In these 
studies, we will focus on quantifying the robustness of melanoma-vascular interactions, 
namely by comparing the proportion of invasive cancer cells that are and are not 
associated with vascular structures.  Additionally, a more detailed analysis of migration 
speeds of individual cells on vessels versus those in the parenchyma will be completed. 
Subsequent studies directly probing the molecular drivers of angiotropic 
migration will be of great interest as follow-up experiments.  Traditionally, the Rho 
GTPase family of proteins, including RhoA, Rac1, and Cdc42, have been extensively 
studied in the context of both 2D and 3D cell migration.  In the work by Hirata et al. 




along vascular structures demonstrate higher RhoA activity and lower Rac1 and Cdc42 
activity relative to cells migrating through the parenchyma.  Based on this finding, we 
also hypothesize that within our system, these various drivers of cell migration will 
differentially control migration along vessels versus through tissues in 3D.  Use of small 
molecule inhibitors of these pathways, such as Y-27632, NSC23766, and ML141, will 
help to reveal such differences in the migration machinery required for movement in 
different topographical settings in vivo.  Within our system, the ability to remove and 
replace a portion of the cranial window at various time points allows for the capacity to 
control the timing of drug delivery.  Thus, it will be possible to study both how inhibition 
of these pathways may affect initial tumor spread after cancer cell inoculation and how 
inhibition affects subsequent angiotropic spreading after establishment of migration along 
vascular structures.   
In addition to studying the role of the classic Rho GTPases in angiotropic 
migration, manipulating the ability for melanoma cells to degrade their extracellular 
matrix may also provide interesting clues into the migration mechanism these cells use 
migration along the vascular interface.  We hypothesize that, given the more flattened 
2D-like morphology of cells migrating along the perivascular space, these cells will not 
be as susceptible to MMP-inhibition as cells migrating in 3D through the parenchyma.  
As such, we anticipate that treatment with broad MMP inhibitors such as Marimastat or 
use of MMP-blocking antibodies like DX-2400/KD014 may slow 3D migration but 




5.3.2 General limitations of these studies 
 One of the major limitations of these studies and our model system is the use of 
immunocompromised mice.  In order to study how a human line of metastatic melanoma 
interfaces with the brain vasculature, we chose to utilize athymic nude mice, which are 
unable to produce T cells and therefore cannot reject any foreign, implanted cells.  While 
these mice are often used for xenograft models in myriad contexts, the recent growth of 
research into the involvement of immune cells in assisting tumor progression highlights 
the importance of incorporating elements of the immune system into cancer models 
(Passarelli et al. 2017).  Though the brain in particular has a very specialized immune 
environment, several recent studies have demonstrated the importance of circulating T 
cells in influencing cancer engraftment in the brain.  For example, T cells have been 
shown to facilitate breast cancer cells in establishing brain metastases by enhancing 
expression of Guanylate-Binding Protein 1, a protein that has also been found to enable 
invasiveness of glioma cells (Mustafa et al. 2018, Li et al. 2011).  In a model of pediatric 
brain cancer, they have been found to be indispensable for enabling growth of low-grade 
glioma stem cells (Pan et al. 2018).  In our system, it is possible that a compromised 
immune system could directly and indirectly affect how melanoma cells and the 
vasculature interact.  Use of murine melanoma cell lines and non-immunocompromised 
mice may reveal additional insights into how the immune system may be involved in 
mediating melanoma-vascular interactions. 
 Another limitation of our studies rises from the use of a cell line derived from 




has been highly utilized in an extensive portfolio of melanoma studies since its 
establishment in 1993 and was chosen in order to enable direct comparison of our studies 
to previously published findings (Brafford et al. 2016).  However, these cells were 
generated through serial passaging of a primary patient-derived melanoma cell line in 
immune deficient mice and ultimate harvesting from the lung metastases which 
developed after the fifth passage (Brafford et al. 2016).  As such, these cells have never 
been exposed to the brain microenvironment and therefore do not necessarily reflect the 
most accurate match for a brain metastasis model.  This discrepancy is especially 
important given that all organs have unique microenvironmental signatures which can 
selectively permit or exclude certain genotypes of cancer cells from forming successful 
metastases (Obenauf & Massague 2015).  As such, melanoma cell lines that metastasize 
to the brain (e.g. B16/F10) or are derived from metastases in the brain (e.g. TXM-13 and 
TXM-18) may be more suitable for future studies utilizing this cranial window model 
(Raz & Hart 1980, Zhang et al. 1991). 
5.3.3 Broader implications of this work 
While much of the research regarding cancer-vascular interactions has been 
focused on melanoma and brain tumors, a few other tumor types have been shown to 
exhibit similar angiotropic interactions.  In particular, direct cancer-vascular interactions 
have been identified in select patients with pancreatic and gynecological cancers (Levy et 
al. 2009, Dyke et al. 2014).  Nonetheless, evidence for angiotropic behavior in other 
cancer types is largely limited, possibly due to a deficiency in the understanding of the 




anticipate that the use of intravital window models such as the one described in Chapter 4 
of this dissertation will help to elucidate the dynamic changes and events that are 
involved in angiotropism and to shed more light on the ways in which these interactions 
are linked to disease progression and patient prognosis.  Through the growth of our 
insight into this phenomenon, we may be able to shift the manner in which we think 
about treating metastatic cancers, by not only focusing efforts on targeting the cells that 
are actively invading into new tissues but also by paying particular attention to those that 
may have escaped via travel along vascular routes and other interfacial surfaces.   
 
5.4 Conclusion 
In this dissertation, we have described our efforts to elucidate mechanisms 
regulating three vascular functions involved in physiological and pathological contexts.  
In Chapter 2, we described our preliminary work investigating the role of Notch signaling 
in mediating endothelial cell mechanics.  In Chapter 3, we presented data to highlight the 
importance of cell contractility in regulating sprouting angiogenesis.  And in Chapter 4, 
we discussed our recent efforts to establish an in vivo window model to study how 
vascular structures may provide topographical cues to enhance and guide metastatic 
spread of melanoma cells. 
  In the three particular areas of vascular research discussed throughout this 
dissertation, including endothelial barrier function, sprouting angiogenesis, and 
involvement in cancer metastasis, major emphasis from these fields has been given to 




critical processes.  However, in more recent years, cytoskeletal mechanics and physical 
microenvironmental cues have emerged as equally central regulators of cellular function 
and communication.  For example, shear stress imparted by blood flow has been 
identified as a critical regulator of both endothelial barrier function and sprouting 
angiogenesis, whereas mechanical properties of the ECM and dimensionality have been 
shown to influence processes including tubulogenesis, barrier establishment, cell 
migration, and cancer metastasis (Polacheck et al. 2017; Galie et al. 2014; Sieminski et 
al. 2004; Urbano et al. 2017; Doyle et al. 2013; Levental et al. 2009).  Here, we have 
shown that both internal contractile forces generated by the cells themselves as well as 
structural factors of the microenvironment are critical in regulating these behaviors, 
thereby adding to the growing body of evidence illustrating that the structure, 
dimensionality, organization of cells can dramatically impact cell function and signaling 
likely through alterations in cell-cell and cell-matrix adhesions.   
Thus, while the three chapters of this dissertation represent three relatively 
discrete avenues of research, they together emphasize the paramount importance of the 
physical forces and interactions involved in regulating many of the functions our 
vasculature serves.  Though many questions still remain and new questions have emerged 
as a result of the work presented here, we believe the findings established in this 
dissertation will help to guide future research and build our understanding of the physical 
cellular and environmental drivers of vascular function.  Continued use and development 
of in vitro models and biophysical approaches such as those outlined in this dissertation 




develop deeper knowledge in these areas, we will be able to more effectively treat 
diseases and design strategies to improve vascular function in broader contexts such as in 
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